Podcasts about American Academy

Charlotte and Jo go deep on jealousy, self-hatred, love, and vulnerability in a conversation that touches on A Separate Peace, The Go-Between, Beowulf, and more. Then the canny and intrepid Maya Binyam joins for a discussion about the category of little girlhood, ambiguity in fiction, and female desire.Maya Binyam is the author of Hangman. Her writing has appeared in the New Yorker, the Paris Review, Best American Short Stories, and elsewhere. She is a 2025 - 2026 Rome Prize Fellow at the American Academy in Rome. Please consider supporting our work on Patreon, where you can access additional materials and send us your guest and book coverage requests! Books discussed on all seasons of the podcast are aggregated here on Bookshop. Questions and comments can be directed to readingwriterspod at gmail dot com. Outro music by Marty Sulkow and Joe Valle.Charlotte Shane's most recent book is An Honest Woman. Her essay newsletter, Meant For You, can be subscribed to or read online for free, and her social media handle is @charoshane.  Jo Livingstone is a writer who teaches at Pratt Institute. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this episode, we discuss… What science really is, both as body of knowledge and a constantly evolving process  Why one study is never enough and the importance of multiple methods, reproducibility, and scientific consensus over time When "gold standard" research falls short and why fields like nutrition require more flexible, creative approaches Science's built-in caution and how new ideas face a high bar of proof, slowing acceptance but strengthening reliability How doubt is manufactured, from the tobacco era to climate science, using fringe voices to challenge strong consensus The role of ideology, and how "freedom" narratives can shape public resistance to scientific evidence Acting without certainty and why we must make public health decisions even when data isn't 100% complete AI and misinformation and the promise and risk of tools like OpenAI in shaping how we consume science Naomi Oreskes Henry Charles Lea Professor of the History of Science Affiliated Professor of Earth and Planetary Sciences ON LEAVE SPRING 2026 emailoreskes@fas.harvard.edu Faculty Assistant: Yaz Alfata Primary Areas of Research: Agnotology; the Political Economy of Scientific Knowledge; History and Philosophy of Earth and Environmental Sciences, Science and Technology Studies (STS); the History of Climate Change Disinformation Secondary Areas of Interest: Science Policy, Science and Religion, Women and Gender Studies   Naomi Oreskes is Henry Charles Lea Professor of the History of Science and Affiliated Professor of Earth and Planetary Sciences at Harvard University. A world-renowned earth scientist, historian and public speaker, she is the author of the best-selling book, Merchants of Doubt (2010) and a leading voice on the role of science in society, the reality of anthropogenic climate change, and the role of disinformation in blocking climate action. Oreskes is author or co-author of 9 books, and over 150 articles, essays and opinion pieces, including Merchants of Doubt (Bloomsbury, 2010), The Collapse of Western Civilization (Columbia University Press, 2014), Discerning Experts (University Chicago Press, 2019), Why Trust Science? (Princeton University Press, 2019), and Science on a Mission: American Oceanography from the Cold War to Climate Change, (University of Chicago Press, 2021). Merchants of Doubt, co-authored with Erik Conway, was the subject of a documentary film of the same name produced by participant Media and distributed by SONY Pictures Classics, and has been translated into nine languages. A new edition of Merchants of Doubt, with an introduction by Al Gore, was published in 2020. Her latest book, with Erik Conway, is The Big Myth: How American Business Taught Us to Loath Government and Love the Free Market, which has been translated to French and Italian. Oreskes wrote the Introduction to the Melville House edition of the Papal Encyclical on Climate Change and Inequality, Laudato Si, and her essays and opinion pieces on climate change have appeared in leading newspapers around the globe, including The New York Times, The Washington Post, The Los Angeles Times, the Times (London), and Frankfurter Allegemeine. Her numerous awards and prizes include the 2019 Geological Society of American Mary C. Rabbitt Award, the 2016 Stephen Schneider Award for outstanding Climate Science Communication, the 2015 Public Service Award of the Geological Society of America, the 2015 Herbert Feis Prize of the American Historical Association for her contributions to public history, and the 2014 American Geophysical Union Presidential Citation for Science and Society. She is a fellow of the American Geophysical Union, the Geological Society of America, the American Association for the Advancement of Science, the American Academy of Arts and Sciences, and the American Philosophical Society. In 2018, she was named a Guggenheim Fellow, and in 2019 she was awarded the British Academy Medal. In 2024, she was awarded the Nonino Foundation "Maestro del Nostro Tempo" award. And in 2025, she was awarded the Volvo Environment Prize for her contributions in "shaping our understanding of how scientific knowledge is collectively constructed and addressing the challenges of misinformation in public discourse."  Curriculum Vitae   Select Publications The Big Myth: How American Business Taught Us to Loath Government and Love the Free Market, 2023 (Bloomsbury Press) Science on a Mission, 2021 (University of Chicago Press) Why Trust Science?, 2019 (Princeton University Press) Science and Technology in the Global Cold War, 2014 (MIT Press) The Collapse of Western Civilization: A View from the Future, 2014 (Columbia University Press)   Collapse of Western Civilization Home Page Merchants of Doubt: How a Handful of Scientists Obscured the Truth on Issues from Tobacco Smoke to Global Warming, 2010. (New York: Bloomsbury Press.) Merchants of Doubt Home Page Merchants of Doubt at the 52nd New York Film Festival, October 8, 2014 Models in Environmental Regulatory Decision Making, Whipple, Chris et al. (fourteen additional authors), 2007. (Washington DC: National Academy of Sciences National Research Council, Board on Environmental Studies and Toxicology), 287 pp. The Rejection of Continental Drift: Theory and Method in American Earth Science, 1999. (New York: Oxford University Press) In the Media Testimony Before the US Senate Budget Committee, Twitter, June 22, 2023 Science Isn't Always Perfect - But We Should Still Trust It, TIME, October 2019 Climate Change Will Cost Us Even More Than We Think, New York Times, October 2019 Escaping Extinction, World Economic Forum, January 2019 Yes, ExxonMobil Misled the Public, LA Times, September 2017 What Exxon Mobil Didn't Say About Climate Change, The New York Times, August 2017 Assessing ExxonMobil's Climate Change Communications (177-2014), Environment Research Letters, August 2017 Scientists Dive Into the Political Fray, PBS Newshour, April 2017 How to Break the Climate Deadlock, Scientific American, November 2015 What Did Exxon Know?, On The Media, November 2015 The Pope and the Planet, The Open Mind, November 2015 Exxon's Climate Concealment, New York Times, October 2015 Naomi Oreskes, a Lightning Rod in a Changing Climate, New York Times, June 2015 A Chronicler of Warnings Denied, New York Times, October 2014 Merchants of Doubt, Documentary from Sony Pictures Classics, 2014 "Why We Should Trust Scientists," TED Talk, June 2014 The 2014 Vatican Environmental Summit: Can a Pope Help Sustain Humanity and Ecology?, New York Times Interview for Cosmologics Magazine Prof. Oreskes discusses her book, "The Collapse of Western Civilization..."  Naomi Oreskes - The Collapse of Western Civilization, Inquiring Minds Podcast "A View From the Climate Change Future," National Public Radio via Boston's WBUR Edited Volumes Oreskes, Naomi, ed., with Homer E. Le Grand, 2001.  Plate Tectonics: An Insider's History of the Modern Theory of the Earth (Boulder: Westview Press), paperback edition February 2003. Edited Journal Volumes Oreskes, Naomi and James R. Fleming, eds. 2000.  "Perspectives on Geophysics," Special Issue of   Studies in the History and Philosophy of Modern Physics, 31B, September 2000.

This year, the American Academy of Allergy, Asthma, and Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress was held in Philadelphia, Pennsylvania, centered on the theme 'Advancing Precision Medicine from Discovery to Patient Care'. While these meetings are filled with complex research and new developments, what matters most to patients and families is what it all means for their daily life with food allergies. Joining us to break it all down in his signature warm and easy-to-understand style is FAACT's Medical Advisory Board Chair, Dr. Shahzad Mustafa, who will share the key takeaways that patients and families should know from this important meeting.Resources to keep you in the know:AAAAIYou can find FAACT's Roundtable Podcast on Apple Podcast, Pandora, Spotify, Podbay, iHeart Radio or wherever you listen to your podcasts.Follow us on Facebook, Instagram, BlueSky, Threads, LinkedIn, Pinterest, TikTok, and YouTube.Sponsored by: GenentechThanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!

The emergency department is one of the most complex decision environments in healthcare. High stakes. Limited time. Overburdened teams. And one critical question asked over and over again: Admit, or safely send home? With growing resource constraints and increasing demand for care, streamlining admissions is no longer optional. It's strategic. Dr. Tom Scaletta MD, CEO of Auscura, Past President of the American Academy of Emergency Medicine (AAEM), and longtime practicing ER physician, discusses how hospitals can recalibrate ER admission decisions using automation, AI, and data-driven insights.  Watch the video version here. In this conversation, we explore: How ER physicians influence hospital utilization and care pathways Why variation in admission rates represents both risk and opportunity How AI and automation support precision-driven clinical decisions The role of 24/7 case management in improving quality and consistency Why patient perception of value can directly impact care outcomes How healthcare leaders can align clinical excellence with financial sustainability This episode is essential for healthcare executives, hospital leaders, emergency physicians, and anyone navigating the shift toward value-based care and AI-enabled decision support. Follow for more conversations at the intersection of healthcare leadership, innovation, and transformation. Connect with Dr. Scaletta on LinkedIn at https://www.linkedin.com/in/tomscaletta Find Dr. Scaletta's work at https://www.auscura.com Subscribe and stay at the forefront of the digital healthcare revolution. Find out why we're the fastest growing digital health channel on YouTube!  The Digital Healthcare Experience is a hub to connect healthcare leaders and tech enthusiasts. Powered by Taylor Healthcare, this podcast is your gateway to the latest trends and breakthroughs in digital health. Learn more at taylor.com/digital-healthcare About Us: Taylor Healthcare empowers healthcare organizations to thrive in the digital world. Our technology streamlines critical workflows such as procedural & surgical informed consent with patented mobile signature capture, ransomware downtime mitigation, patient engagement and more. For more information, please visit imedhealth.com   The Digital Healthcare Experience Podcast: Powered by Taylor Healthcare Produced by Naomi Schwimmer  Hosted by Chris Civitarese Edited by Eli Banks Music by Nicholas Bach  

Marc Cox welcomes Mary Vought, Vice President of Strategic Communications at Heritage, to discuss recent developments in transgender care for minors, emphasizing the American College of Pediatricians' stance against medical interventions for children and contrasting it with the American Academy of Pediatrics' positions. The conversation highlights parental rights, teacher accountability, and a major Supreme Court ruling in California that strengthens transparency in schools nationwide. Vought stresses the broader implications for common sense policymaking, education, and the upcoming spring school board elections, framing the debate around protecting children and parental authority. Hashtags: #MaryVought #ParentalRights #TransgenderCare #AmericanCollegeOfPediatricians #SupremeCourt #EducationPolicy #MarcCox #HeritageFoundation #SchoolBoardElections #ChildProtection

How do we decide who gets financial support from the government? Usually, it comes down to the federal poverty line. You might think a lot of data and research goes into establishing that number. But in reality, it’s much squishier. So squishy in fact that it involves Jello... Today, a special episode brought to us by our friends at Control F: the surprising history of the federal poverty line. Sources in this episode: U.S. Census Bureau Timeline of Poverty Measure, 2014 How the U.S. Census Bureau Measures Poverty, 2022 What does living at the poverty line look like?, USA Facts, 2023 Poverty Guidelines vs Poverty Thresholds, U.S. Department of Health and Human Services Poverty Line Matrix, U.S. Department of Health and Human Services, 2026 Remembering Mollie Orshansky — The Developer of the Poverty Thresholds, Society Security Administration, 2008 Relatively Deprived, New Yorker, 2006 Mollie Orshansky, Statistician, Dies at 91, The New York Times, 2007 Mollie Orshansky: Inventor of the Poverty Line, NPR, 2007 Thrifty Food Plan, U.S. Department of Agriculture, 2021 Thrifty Food Plan: Better planning and accountability could help ensure quality of future reevaluations, U.S. Government Accountability Office Report to Congressional Requesters, 2022 Family Food Plans and Food Costs, U.S. Department of Agriculture, 1962 The Indians in the Lobby, Season 3, Episode 8, The West Wing, 2001 NPR audience call out on SNAP benefits, 2025 Legacies of the War on Poverty, The ANNALS of the American Academy of Political & Social Science, 2024 Control F wants to answer your questions about how our world works! Click here to submit a question using their online form, or email the team at ControlF@kuow.org Do you have a tip for the Booming team? Give us a call at (206) 221-7158 and leave a voicemail. You can also email us at booming@kuow.org.Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/boomingnotes.Booming is a production of KUOW in Seattle, a proud member of the NPR Network. Our editor is Carol Smith. Our producers are Lucy Soucek and Alec Cowan. Our hosts are Joshua McNichols and Monica Nickelsburg.Support the show: https://kuow.org/donateSee omnystudio.com/listener for privacy information.

Podcast summary of articles from the December 2025 edition of the Journal of Emergency Medicine from the American Academy of Emergency Medicine.  Topics include nerve blocks, TEE in cardiac arrest, smartwatch detected arrhythmias, point of care EEG, toxicology, and stoma bleeding.   Guest speaker is Dr. Gary Vilke from JEM Reports.

The Alliance for Civics in the Academy hosts "What Counts as Success? Assessing the Impact of Civics in Higher Ed" with Trygve Throntveit, Rachel Wahl, Joseph Kahne, and Peter Levine on February 18, 2026, from 9:00-10:00 a.m. PT. As higher education renews its commitment to civic education, questions about how to define and measure success have become increasingly urgent. This webinar examines the strengths and limitations of common metrics and considers how different measures reflect competing visions of civic purpose in higher education. Participants explore emerging frameworks for assessing civic learning and engagement, and discuss how institutions can align assessment practices with their educational missions and democratic goals. ABOUT THE SPEAKERS Rachel Wahl is an associate professor in the Social Foundations Program, Department of Educational Leadership, Foundations, and Policy at the School of Education and Human Development at the University of Virginia. She also serves as Director of the Good Life Political Project at the UVa Karsh Institute of Democracy. Her research focuses on learning through public dialogue between people on opposing sides of political divides. Her most recent book is Keeping Our Enemies Closer: Political Dialogue in Polarized Democracies (University of Pennsylvania Press, forthcoming October 2026). Her prior research focused on efforts by community activists to change police officers' beliefs and behavior through activism and education, which is the subject of her first book, Just Violence: Torture and Human Rights in the Eyes of the Police (Stanford University Press, 2017). Her research has been funded by donors such as the Educating Character Initiative, the Spencer Foundation and National Academy of Education, the Carnegie Corporation, and the federal Institute of International Education.  Joseph Kahne is the Ted and Jo Dutton Presidential Professor for Education Policy and Politics and Director of the Civic Engagement Research Group (CERG) at the University of California, Riverside. Professor Kahne's research focuses on the influence of school practices and digital media on youth civic and political development. For example, with funding from the Institute of Educational Sciences (IES), and in partnership with scholars from Ohio State, Brown, and UCR, CERG has launched and is studying the impact of Connecting Classrooms to Congress (CC2C). CC2C is a social studies curricular unit that enables students to learn and deliberate about a controversial societal issue and then participate in an online townhall with their Member of Congress. In addition, Kahne and CERG are currently studying the Educating for American Democracy Roadmap. This work takes place through a partnership with reformers and school districts in NM, OK, and LA. In addition to studying the impact of these curricular experiences on young people's civic development, with John Rogers, we are currently devoting particular attention to the politics of democratic education. We are examining ways the political contexts of school districts shape possibilities for democratic education and the varied ways educators respond.  Professor Kahne was Chair of the MacArthur Foundation's Youth and Participatory Politics Research Network. Kahne was a member of the American Academy of Arts and Sciences Commission on the Practice of Democratic Citizenship. He currently chairs the Educating for American Democracy Research Task Force. Professor Kahne is a member of the National Academy of Education and a Fellow of the American Educational Research Association. He can be reached at jkahne@ucr.edu and his work is available at https://www.civicsurvey.org/ Trygve Throntveit, PhD, was appointed Research Professor in Higher Education and Associate Director of the Center for Economic and Civic Learning (CECL) at Ball State University in August of 2025. During the previous five years, he served as Director of Strategic Partnership and Civic Renewal Programming at the Minnesota Humanities Center (MHC), and as Global Fellow for History and Public Policy at the Woodrow Wilson International Center for Scholars. At MHC, Dr. Throntveit expanded the Third Way Civics (3WC) initiative for undergraduate civic learning--which he first developed with partners at Ball State and Southeastern Universities in 2019--into a multi-state program, training dozens of faculty in Minnesota, Indiana, Florida, Missouri, and Montana to infuse student-centered, active civic learning into their regular courses and helping several colleges and universities build the original, US history and politics version of 3WC into their general curricula. As a result of his work on Third Way Civics, was selected by Campus Compact and the Civic Learning and Democracy Engagement coalition to co-author an upcoming guide to designing and implementing rigorous civic learning opportunities across the undergraduate curriculum, and has delivered presentations and workshops on 3WC and civic learning more generally across the United States as well as Austria, Germany, Japan, and Korea. Trained as a historian, Dr. Throntveit is an active scholar in the fields of history and political theory as well as civic learning, having published articles and books examining past and present developments in US politics, foreign policy, and social thought and served for eight years as editor of The Good Society, the journal of the transdisciplinary Civic Studies field. He has taught at Harvard University, Dartmouth College, and Minnesota State University-Mankato, and has overseen public humanities programs bringing communities into productive conversation across their differences on issues as diverse as election integrity, US-Tribal relations, and water use. Dr. Throntveit lives and works in Minneapolis, where oversees the increasingly national 3WC initiative and also directs the Twin Cities-based Institute for Public Life and Work, which he co-founded with Harry C. Boyte and Marie-Louise Strom in 2021.  Moderator Peter Levine is a philosopher and political scientist who specializes on civic life and has helped to develop Civic Studies as an international intellectual movement. In the domain of civic education, Levine was a co-organizer and co-author of The Civic Mission of Schools (2003), The College, Career & Citizenship Framework for State Social Studies Standards (2013) and The Educating for American Democracy Roadmap (2021). He is also the author of eight books, including most recently We Are the Ones We Have Been Waiting For: The Promise of Civic Renewal in America (Oxford University Press, 2013) and What Should We Do? A Theory of Civic Life (Oxford University Press, 2022).

Dorothy Roberts joins Let's Talk Memoir for a conversation about her father's interviews beginning in the 1930s with over 500 back-white couples who crossed the color line in Chicago,  moving to memoir to explore more personal experiences and feelings, growing up in a mixed race family, shifting the lens onto herself, thinking about identity, finding answers via the writing process, staying motivated and organized while working with heaps of material, the mystery in memoir, bringing the reader into the discovery process, the adventure of not knowing, looking for evidence people can love across racial boundaries, and her new book The Mixed Marriage Project: A Memoir of Love, Race and Family.   Info/Registration for Ronit's 10-Week Memoir Class Memoir Writing:Finding Your Story https://www.pce.uw.edu/courses/memoir-writing-finding-your-story   Also in this episode: -taking breaks -working with source material -the possibility of racial harmony in America   Books mentioned in this episode: -The Color of Water by James McBride -South to America by Imani Perry -The Warmth of Other Suns by Isabel Wilkerson -The Yellow House by Sarah M. Broom   Dorothy Roberts is the George A. Weiss University Professor of Law and Sociology at the University of Pennsylvania, where she directs the Penn Program on Race, Science, and Society. The author of five books, including Killing the Black Body, a MacArthur Fellow, and member of the American Academy of Arts and Sciences, she lives in Philadelphia, Pennsylvania.   Connect with Dorothy: Website: https://www.dorothyeroberts.com/ Get the book: https://www.simonandschuster.com/books/The-Mixed-Marriage-Project/Dorothy-Roberts/9781668068380   – Ronit's writing has appeared in The Atlantic, The Rumpus, The New York Times, Poets & Writers, The Iowa Review, Hippocampus, The Washington Post, Writer's Digest, American Literary Review, and elsewhere. Her memoir WHEN SHE COMES BACK about the loss of her mother to the guru Bhagwan Shree Rajneesh and their eventual reconciliation was named Finalist in the 2021 Housatonic Awards Awards, the 2021 Indie Excellence Awards, and was a 2021 Book Riot Best True Crime Book. Her short story collection HOME IS A MADE-UP PLACE won Hidden River Arts' 2020 Eludia Award and the 2023 Page Turner Awards for Short Stories.  She earned an MFA in Nonfiction Writing at Pacific University, is Creative Nonfiction Editor at The Citron Review, and teaches memoir through the University of Washington's Online Continuum Program and also independently. She launched Let's Talk Memoir in 2022, lives in Seattle with her family of people and dogs, and is at work on her next book.   More about Ronit: https://ronitplank.com Subscribe to Ronit's Substack: https://substack.com/@ronitplank   Follow Ronit: https://www.instagram.com/ronitplank/ https://www.facebook.com/RonitPlank https://bsky.app/profile/ronitplank.bsky.social

This month we turn our attention to Poison Control, beginning with an overview of why children are uniquely vulnerable to toxic exposures. In this episode, our host, Paul Wirkus, MD, FAAP and guest Michael Moss, MD review common pediatric ingestions, household risks, and explain factors that increase children's vulnerabilities.We also take a behind-the-scenes look at how the nation's poison control system works - how calls are triaged, who provides guidance, and how centers collaborate across the country to deliver real-time, evidence-based recommendations. Most importantly, we emphasize when and how to use this invaluable resource.If you have a concern about a possible poisoning, call 1-800-222-1222 to reach your local poison control center anywhere in the United States.Have a question? Email questions@vcurb.com. They will be answered in week four.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Send a textAbout Dr. Dr. Cecelia KoettingDr. Koetting is an assistant professor at the University of Colorado School of Medicine in the Department of Ophthalmology in Denver, CO. Her primary focus is on anterior segment and ocular surface disease, neuro-optometry, and perioperative care. She partakes in clinical research and has served as an externship director and adjunct faculty for several schools and colleges of optometry. Dr. Koetting is a member of Intrepid, a fellow in the American Academy of Optometry, a diplomate of the American Board of Optometry, an active member of AOA, and has served as both a local and state officer within AOA. She was named young optometrist of the year by the state of Virginia. Dr. Koetting lectures locally, nationally, and internationally at conferences; continually contributes articles to; and serves on the editorial board for multiple publications.

Today's guest is Dr. King Chung from MGH Institute of Health Professions. She is an educator, a researcher, an inventor, and a humanitarian. Her areas of expertise are in amplification, calibration, and humanitarian audiology. Dr. Chung's research focuses on how to improve signal processing strategies of hearing aids and cochlear implants. Her research team is also working on developing a universal hearing aid app and calibration system to improve access to amplification and equipment, especially in low- to mid-income countries. Additionally, she is a humanitarian who has been leading students and audiologists to provide free hearing services for underserved and unserved populations around the world. Dr. Chung has 3 granted U.S. patents with two more pending. She was a Fulbright Scholar in Brazil in 2019 and a recipient of the Humanitarian Award from the American Academy of Audiology in 2020. Today, we are going to discuss Dr. Chung's project on developing a universal hearing aid/amplification app using methods disclosed in two complementary patents.

Presenter: Marcus Shaker, MD, MSc, FAAP, FACAAI, FAAAAI Financial and space limitations are two of the most pressing issues facing allergists and immunologists in academic practice. Fortunately, negotiation principles, like BATNA and ZOPA, and disruptive innovation tactics can help address these common issues. To learn more, we recently spoke with Dr. Marcus Shaker. Not only is he a Professor of Pediatrics and Medicine at the Dartmouth Geisel School of Medicine in New Hampshire, but he also spoke about this topic at the 2026 American Academy of Allergy, Asthma, & Immunology Annual Meeting.

Presenter: Mustafa Ozcam, PhD Emerging research is redefining the role of the gut microbiome in food allergy and immune tolerance. Here to share some of the most groundbreaking findings is Dr. Mustafa Ozcam. He discusses how gut microbes metabolize allergenic proteins, shape immune development, and serve as potential biomarkers to predict oral immunotherapy success in food allergy patients. Dr. Ozcam is an Assistant Professor of Microbiology and Immunology at the University of Maryland School of Medicine, and he spoke about this topic at the 2026 American Academy of Allergy, Asthma, and Immunology Annual Meeting.

Contributor: Taylor Lynch MD Educational Pearls: Melatonin is an endogenous hormone released primarily by the pineal gland Also released by extrapineal regions in the retina, the GI tract, and some immune cells Peak secretion occurs at night and is suppressed during the day Secretion and production decrease with age Older patients experience the greatest improvement in sleep latency and sleep quality Mechanism of action in the suprachiasmatic nucleus of the hypothalamus MT1 receptor Reduces normal firing MT2 receptor Shifts the circadian rhythm FDA approved for insomnia Decreases sleep latency by 7 minutes Increases total sleep time by 8 minutes FDA approved for circadian sleep-wake disorders Jet lag Most effective in west-to-east travel Best if crossing at least 5 time zones Shift work A study examined ED physicians and nurses with rotating shifts Modest increase in deep sleep percentage No difference in cognition or reaction time the day after taking melatonin Nurses on rotating night shifts experienced increased total sleep time by 20 minutes Dosing 0.5 - 3 mg is the most evidence-based dosing Higher doses increase the risk of rebound grogginess but do not improve outcomes References Ahmad SB, Ali A, Bilal M, et al. Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders. Cell Mol Neurobiol. 2023;43(6):2437-2458. doi:10.1007/s10571-023-01324-w Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;(2):CD001520. doi:10.1002/14651858.CD001520 Morgenthaler TI, Lee-Chiong T, Alessi C, Friedman L, Aurora RN, Boehlecke B, Brown T, Chesson AL Jr, Kapur V, Maganti R, Owens J, Pancer J, Swick TJ, Zak R; Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep. 2007 Nov;30(11):1445-59. doi: 10.1093/sleep/30.11.1445. Erratum in: Sleep. 2008 Jul 1;31(7):table of contents. PMID: 18041479; PMCID: PMC2082098. Thottakam BMVJ, Webster NR, Allen L, Columb MO, Galley HF. Melatonin Is a Feasible, Safe, and Acceptable Intervention in Doctors and Nurses Working Nightshifts: The MIDNIGHT Trial. Front Psychiatry. 2020;11:872. Published 2020 Aug 27. doi:10.3389/fpsyt.2020.00872 Summarized and edited by Jorge Chalit, OMS4 Donate: https://emergencymedicalminute.org/donate/ Join our mailing list: http://eepurl.com/c9ouHf

In this episode of PEM Currents: The Pediatric Emergency Medicine Podcast, we take a structured, evidence-based approach to the acute treatment of migraine in children and adolescents. From confirming the diagnosis and screening for concerning features to optimizing outpatient therapy and executing a protocolized emergency department strategy, this episode walks through what works. We review the role of NSAIDs and triptans, clarify how IV fluids and ketorolac fit into care, and provide a stepwise framework for dopamine antagonists, valproate bridge therapy, DHE protocols, steroids, discharge planning, and admission decisions. Practical dosing, reassessment timing, and family-centered communication strategies are emphasized throughout. Learning Objectives Recognize the clinical features of pediatric migraine and distinguish it from secondary causes of headache. Implement a stepwise, evidence-based emergency department approach to acute pediatric migraine, including appropriate medication selection and timing of reassessment. Develop safe discharge and follow-up plans by defining treatment endpoints, minimizing medication overuse, and identifying patients who require referral or inpatient management. References 1. Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice Guideline Update Summary: Acute Treatment of Migraine in Children and Adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019;93(11):487-499. doi:10.1212/WNL.0000000000008095. 2. Patterson-Gentile C, Szperka CL. The Changing Landscape of Pediatric Migraine Therapy: A Review. JAMA Neurology. 2018;75(7):881-887. doi:10.1001/jamaneurol.2018.0046. 3. Bachur RG, Monuteaux MC, Neuman MI. A Comparison of Acute Treatment Regimens for Migraine in the Emergency Department. Pediatrics. 2015;135(2):232-238. doi:10.1542/peds.2014-2432. 4. Ashina M. Migraine. The New England Journal of Medicine. 2020;383(19):1866-1876. doi:10.1056/NEJMra1915327. 5. Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the Acute Treatment of Migraine in Children and Adolescents. The Cochrane Database of Systematic Reviews. 2016;4:CD005220. doi:10.1002/14651858.CD005220.pub2. Transcript This transcript was generated using Descript automated transcription software and has been reviewed and edited for accuracy by the episode's author. Edits were limited to correcting names, titles, medical terminology, and transcription errors. The content reflects the original spoken audio and was not substantively altered. And today we're gonna talk about the acute treatment of migraine headache in children and adolescents. This is bread and butter for the PED, requires precise diagnosis and evidence-based treatment. We're gonna talk about making that diagnosis, red flags, outpatient and ED treatment, as well as some second-line agents, admission decisions, and a whole lot more. So migraine in children is defined by three criteria, and at least five attacks lasting two to 72 hours. So you gotta have at least two of the following: pulsating or throbbing quality, moderate to severe intensity, aggravation by routine activity, and a unilateral location. Although in children, it's often bilateral, plus at least one of nausea or vomiting and photophobia and/or phonophobia. In children headaches are frequently bilateral, bifrontal, bitemporal. The duration might be shorter than adults, especially in kids under second or third grade. And you may have to infer whether or not they have photophobia from their behavior. Like does the child close their eyes or wanna go into a dark room? In the emergency department, we're often diagnosing based on pattern recognition plus exclusion of dangerous secondary causes. Or even more often than that, the patient comes in and says, I've got a migraine. Before I move on to treatments, let's talk about some red flags where you might wanna pause and not just jump to migraine therapy. And the mnemonic SNOOP can be helpful here. And it stands for S for systemic symptoms such as fevers, myalgia, weight loss, or another S, secondary risk factors such as an immune deficiency, cancer, pregnancy, N for neurologic signs, papilledema, focal deficit, confusion, seizures. O onset sudden, or thunderclap. Migraines are often a little more gradual than that. The other O is older age, or technically younger age too, younger than five years or older than 50. Hopefully those patients are not coming into the pediatric emergency department. And then pattern changes, these new symptoms in a previously stable pattern. Don't ignore that. And precipitants, you know, is it worse with Valsalva, position change, or under significant exertion? If these signs are present, you'll probably wanna take a pause and just not throw migraine treatment at the patient. If they're stable, MRI is the preferred imaging modality, but a very sick patient, it'd be okay to get a head CT. If you've got a normal neurologic exam, there's no red flags. Again, you don't need routine imaging for migraine headaches. So let's talk about treatment. So hopefully patients have actually started to treat their headache before they arrive in the emergency department. If they haven't, it's a good idea to have some triage protocols in place. So ibuprofen, 7.5 to 10 milligrams per kilogram, 10 milligrams per kilogram is superior to placebo and it's superior to acetaminophen at two hours. So that's what we would use. Early treatment's critical. So ideally within the first hour of onset. So that's why triage protocols help. We'll give kids 10 mg per kg of ibuprofen and like 30 ounces of Gatorade. Blue is often the first Gatorade choice, though that's not an evidence-based statement. You can also use naproxen, but most of the studies are on ibuprofen. If NSAIDs fail, many adolescents and some older children will be prescribed triptans. The best evidence currently supports sumatriptan plus naproxen or zolmitriptan nasal spray. Rizatriptan is FDA approved down to age six. Adolescents respond to these agents better than younger children, and the route matters. The nasal formulations help when nausea is prominent. Families should be counseled to treat early, use weight-appropriate dosing, and avoid using acute medications more than 10 days per month. Often patients will have already taken an NSAID and a triptan before they get to the ED, and that's where we get into the treatment of refractory migraine. Now this is most of the patients that I will see, and before we push medications, let's briefly review ED treatment goals. You either want the patient headache free. Back to their baseline or mild descending pain. So a pain score of one to three. If you don't reach one of those endpoints and it's not agreed upon with the patient and their family, you've not completed treatments. You should do a reassessment within one hour after each intervention. And let's face it, if you're not reassessing within an hour and defining treatment goals, you're not practicing protocolized migraine care. So in the emergency department, many of you may be familiar with the migraine cocktail. So what is that? In general, it's a dopaminergic agent such as prochlorperazine or metoclopramide plus ketorolac, plus IV fluids. Let's take a look at all three of those components and see if you can guess which one is actually the one that can abort the migraine. So fluids are commonly given in pediatric migraine, but they alone do not treat it. They're helpful. Many patients have been throwing up or a bit dehydrated, but there are small randomized trials that show essentially no meaningful pain reduction in patients that get IV fluids alone. Well, what about ketorolac? Toradol, like that's the first thing you give to a kid with a kidney stone, right? It does help, but it's really adjunctive. So the main first-line agents for refractory or status migrainosus in the emergency department are the dopamine antagonists, and the first-line treatment for most patients is prochlorperazine or Compazine. The dose is 0.15 milligram per kilogram IV. The max is 10 milligrams. This is the backbone of ED migraine care. And why do they work? Well, migraines aren't just some random vascular headache. This is an inherited disorder with central pain pathways gone awry. Dopamine plays a large role in that pain, nausea, hypersensitivity, amplification of symptoms and more that, frankly, I won't get into this podcast because molecules hurt my head. The dopamine antagonists treat the headache, they reduce the nausea, and they just tamp down this process. Overall, the response rates approach 85%. Some studies have suggested that the response rate is about 77% at an hour and 90% at three hours. If you add the ketorolac and IV fluids, you get your response rate up to about 93 to 94%. These agents really do work well together. There have been randomized trials comparing IV prochlorperazine versus ketorolac. 85% of prochlorperazine patients achieved headache relief versus only 55% of ketorolac patients. So ketorolac helps, but really it's the prochlorperazine. Metoclopramide, or Reglan, is used in a lot of centers as well. There are some smaller studies in children and adolescents that show that prochlorperazine is more effective, but if kids have an adverse reaction, more on that in a moment, or they prefer metoclopramide because they've responded to it in the past, it's okay to go with it as well. Right. So what does it actually look like when you give the migraine cocktail to a patient? I think it's important to explain to patients and families what to expect, and if this is a teenager, I'm talking to them directly. I mean, they're getting the medication first and foremost. I tell them that the most effective way to treat their headache is with an IV. This often causes lots of angst, even in older teenagers. The medication just does not get to the brain as effectively and fast enough if you take it by mouth. Many patients who get the dopaminergic agents, so prochlorperazine, will invariably feel jittery or anxious or like they gotta move or like they got ants in their pants. I tell them to expect this so they're not surprised and worried when it happens. I tell them that once they start feeling that way, it means the medicine is probably working. They need to hit the nurse button and we're gonna get them up and have them take a walk. This fixes it for the majority of patients just getting up and moving. In adult centers, even with the initial administration of the prochlorperazine or as sort of a reflexive response to any of those symptoms, they just give a slug of IV Benadryl. There's some studies in adolescents especially that this may decrease the effectiveness of the IV agents you're giving in the first place, and it may also increase return rates to the ED. So I will use IV diphenhydramine if getting up and moving around isn't working, or if the distress is significant, or if the patient clearly indicates they've needed it in the past. So if after the migraine cocktail, the patient has met their pain goals and the reassessment is favorable, they can go home to outpatient follow-up. How about if the headache got better, but not all the way? It's usually when the initial migraine cocktail didn't achieve the pain endpoints fully, like it helped partially. If the dopamine blockade didn't do anything, valproate is unlikely to rescue the case. And so valproate works on GABA and it stabilizes some of these pain processes, but the dopaminergic agent needs to have done something first for valproate to work. Per the most common protocol, you give an initial dose of IV valproate, then you discharge the patient home on Depakote ER. So oral valproic acid under 10 years old or under 50 kilograms, 250 milligrams PO twice a day for two weeks, or older than 10 or greater than 50 kilos, 500 milligrams twice a day for two weeks. This is the extended release and it's most helpful if you give the first oral dose in the emergency department. So that's why it's very important to build this protocol in advance. If you don't have IV valproate, then don't just give the patient oral valproate, and definitely don't prescribe an oral course for discharge. All right, well, what about DHE? Dihydroergotamine for refractory or status migrainosus? Generally, this is only given at pediatric centers where you have neurology coverage. It's contraindicated if you've had another dose of DHE within 14 days, or you've had any triptan of any sort within 24 hours, and you must obtain a pregnancy test in adolescent females before giving it. The dosing for less than 30 kilograms is 0.5 milligram. At least 30 kilograms is one milligram. You give 50% of the dose over three minutes, then the remaining 50% over 30 minutes. If this is gonna work, the patients are gonna start feeling wretched at first. They're gonna get very nauseous and they're gonna vomit. They're gonna have flushing, and you'll see transient hypertension. Most of that resolves within the hour in most centers. If you're committing to DHE, you're kind of bringing the patient into the hospital anyway, though some facilities will have DHE done in the emergency department with close outpatient follow-up. Either way, it's really best practice to involve child neurology if you're giving DHE. Alright, well what about steroids? They give those in grownups too, right? Steroids really only have a role for recurrence prevention in children. So for kids that have a history of returning within 72 hours for rebound headache, you can give dexamethasone 0.6 milligram per kilogram IV dose, the max of 10 milligrams. You do not discharge them home on a steroid prescription or a Medrol dose pack or something else, and this can cut the recurrence risk down a bit. There's other therapies out there like magnesium and ketamine. There's just not enough evidence there. And the purpose of this episode is to discuss the therapies that have good evidence behind them and should be part of protocols across the country. Some patients are unfortunately not responsive to emergency department therapy and need admission. The main inpatient therapy is the DHE protocol. If they're not DHE eligible, they haven't tolerated it well or it's unavailable, admission's unlikely to help them unless they just need some IV fluids to help them get back up on their feet. You should consult neurology if the headache goals are not met after maximizing ED therapy for advice. And we should definitely avoid opioids. They don't treat patients with migraines. They increase recurrence risk. They increase revisit rates. Again, the dopamine antagonist prochlorperazine, it's superior for sustained relief when families ask about them, and fortunately they're asking about opioids far less. We use medications that treat the migraine pain pathways and signaling. We don't just wanna mask the pain. All right, so that's all I've got on the acute management of migraine headaches, especially in the emergency department. Remember that migraine care in the ED should be protocolized and evidence-based. IV fluids are supportive. Prochlorperazine is the first line, or you can use metoclopramide as well. Ketorolac is an adjunctive therapy. Valproate is next line. If you've gotta escalate, and DHE is specialized therapy, you can start in the ED, but most of these patients are getting admitted. Dexamethasone or steroids in children can reduce recurrence risk, but they're not really part of the acute management. You should definitely define the endpoints and structurally and systematically reassess patients at an hour. The goal is to get them feeling better to a defined endpoint and to restore function. There is evidence-based pediatric emergency migraine care. You should understand that, plus how to explain why these agents are being given and some of the side effects to patients and families. I find that that approach increases your likelihood of buy-in and success. Alright, so that's it for this episode on the Acute Management of Migraine Headaches in Children and Adolescents. I hope you found it helpful and I can pretty much guarantee that you're gonna see a patient with a migraine on your next shift. If you've got any feedback or comments, send them my way. If you like this episode, leave a review on your favorite podcast site. It helps more people find the show. Or recommend it to a colleague. If there's other topics that you'd like to hear, send them my way for the Pediatric Emergency Medicine podcast. This has been Brad Sobolewski. See you next time.    

In this powerful episode, longtime HPNA member Linda Blum, APRN shares experiences from the last few years of her rich nursing career in volunteerism —training incarcerated caregivers in a California state prison hospice program. Linda explores the ethical complexity of end-of-life care behind bars, from POLST conflicts and CPR decisions to pain management in a correctional setting where Medicare rules don't apply.  Through ELNEC education and interdisciplinary collaboration, she's helping nurses, correctional officers, and incarcerated caregivers reclaim agency and restore dignity at the end of life. This conversation examines moral distress, serious illness communication, and the transformative power of “risking love” in some of the most marginalized settings.  A moving reflection on bearing witness, professional courage, and the light within us all. About Humane Prison Hospice Project  The Humane Prison Hospice Project is developing a humanitarian, cost-effective, and transformative solution to ensure that those aging and dying in prison receive compassionate care. Since 2017, the Humane Prison Hospice Project has worked to ensure that incarcerated individuals receive compassionate end-of-life care from trained peers. Humane implements a comprehensive 80-hour, 15-module curriculum to train incarcerated individuals as peer caregivers, equipping them with the skills to provide hands-on care and emotional support to their aging and terminally ill peers. Graduates of this program are part of a growing movement to humanize end-of-life care behind bars. Since launching this initiative, we have trained over 150 peer caregivers across California prisons, and are bringing our programming to three states—Michigan, Washington, and Oregon—marking our first step toward national replication. Learn more on their website: https://humaneprisonhospiceproject.org/  For anyone listening who has experience in hospice, nursing, programming in prisons or facilitating, and you live in CA, WA, MI, or OR, Humane is seeking volunteer facilitators who participate in trainings for peer caregivers in prisons across each state. We'd love to hear from you -- please reach out to Camila Ryder at camila@humaneprisonhospiceproject.org with your name, location, and any relevant experience. If you're interested in learning more, register via Zoom for one of our virtual monthly Informational Meetings.      Linda Blum, GNP, MSN, RN   Linda Blum, GNP, MSN, RN, is a retired gerontological nurse practitioner living in California. Born and raised in New York State, she moved to the Bay Area over 45 years ago. Her early career included work in virology and immunology laboratories before she left a PhD program after the birth of her first child. She later worked as a birth doula and photographer and entered nursing school intending to become a nurse midwife. Instead, her path led her to the care of people with serious illness. She often jokes that she has a poor sense of direction and found end of life, not beginning of life, as she prefers anxious children to anxious parents.  Linda worked in home infusion and home hospice as a case manager and manager before returning to school for her at UCSF and then completing a palliative medicine fellowship at the VA in Palo Alto. She was  hired as the first clinician to provide palliative care/medicine consultation at California Pacific Medical Center.  Since retiring in 2023, Linda has volunteered her time and expertise with the Humane Prison Hospice Project, where she facilitates training for incarcerated individuals serving as peer caregivers. Her passion is helping to train nurses and professional staff in the carceral setting using a modified ELNEC curriculum.  Linda enjoys traveling, caring for her grandchildren, and telling silly jokes and puns. Her spirit animal is a penguin—preferably a Gentoo—and if you ask for photos, your inbox may quickly overflow.     Brett Snodgrass, DNP, FNP-C, ACHPN®, FAANP Dr. Brett Snodgrass has been a registered nurse for 28 years and a Family Nurse Practitioner for 18 years, practicing in multiple settings, including family practice, urgent care, emergency departments, administration, chronic pain and palliative medicine. She is currently the Operations Director for Palliative Medicine at Baptist Health Systems in Memphis, TN. She is board certified with the American Academy of Nurse Practitioners. She is also a Fellow of the American Association of Nurse Practitioners and an Advanced Certified Hospice and Palliative Nurse. She completed a Doctorate of Nursing Practice at the University of Alabama – Huntsville. She is a nationally recognized nurse practitioner speaker and teacher. Brett is a chronic pain expert, working for more than 20 years with chronic pain and palliative patients in a variety of settings. She is honored to be the HPNA 2025 podcast host. She is married with two daughters, two son in laws, one grandson, and now an empty nest cat. She and her family are actively involved in their church and she is an avid reader.

This podcast explores the science, policy, and clinical reasoning behind updated pediatric immunization schedules. This CE episode reviews current 2026 American Academy of Pediatrics and US Department of Health and Human Services pediatric immunization recommendations, examines the data supporting vaccine timing, and compares U.S. practices with international approaches. Through a patient-centered lens, the discussion highlights how shared decision-making can be applied in real-world pediatric care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In today's episode we will be discussing educational policy and its nuances in the U.S. across all States.Our guests today include, Dr. Ben Kern - an Associate Professor in PETE in the College of Health Sciences, Kinesiology, and Health at the University of Wyoming. Dr. Kern is a national leader in physical education policy research. He currently leads the School Health Map and facilitated the development of the State of the States Policy Report. Dr. Kern is focused on policy implementation and advocacy to strengthen physical education and physical activity nationwide in schools. Dr. Kern has also established a unique line of inquiry that investigates the individual dispositions of physical education teachers and related socializing agents that impact their adoption of teaching practices consistent with promoting student physical literacy. Our next guest is Dr. Lisa Paulson is an assistant professor in the Department of Applied Human Sciences at the University of Minnesota Duluth. She currently serves as chair of the SHAPE America Physical Activity Council and co-chair of the SHAPE America PETE Standards Task Force. Her scholarship focuses on physical education policy work and school-based physical activity promotion.Originally from The Netherlands, our final guest is Hans van der Mars (Ph.D., The Ohio State University, 1984) is Professor Emeritus at Arizona State University where he oversaw the undergraduate, master's and doctoral degree programs in Physical Education Teacher Education/Sport Pedagogy. Dr. van der Mars is widely published, (co-) and authoring over 170 published research papers, professional papers, book chapters, proceedings papers, and three textbooks. He presents frequently at international, national, regional and state level conferences. Moreover, he has provided over 85 continuing professional development/outreach workshops and guest lectures for K-12 physical educators, teachers, graduate students, and colleagues nationally and internationally.Over Dr. van der Mars illustrious career, he has represented the physical education profession in various capacities of leadership, scholarship, and service.  Far too extensive to share today, but some examples include: Research Fellow distinction in the Society of Physical and Health Educators of America (2005), the American Academy of Kinesiology & Physical Education (2006), the North American Society of Health, Physical Education, Recreation, Sport, and Dance Professionals (2009), the International Association for Physical Education in Higher Education (AIESEP, 2019), and National Association of Kinesiology in Higher Education (NAKHE 2021). Hans has also been recognized with the following honors: the National Association for Sport & Physical Education's (NASPE) Physical Education Teacher Education Honor Award (2011) and the Curriculum & Instruction Academy Honor Award (2013). In 2018, he was inducted into the SHAPE America Hall of Fame. In 2020, the National Association of Kinesiology in Higher Education (NAKHE) recognized him with the Distinguished Scholar Award. In 2021, The Ohio State University's College of Education and Human Ecology presented him with its Alumni Career Achievement Award, while SHAPE America recognized him with the Luther Halsey Gulick Award in 2023. And in 2024, he received the White House Presidential Lifetime Achievement Award.https://schoolhealthmap.wygisc.org/

How can understanding your subconscious mind transform your physical and emotional well-being? What role does forgiveness play in releasing deep-rooted trauma and enhancing your life? In this powerful episode of me&my health up, clinical nutritionist and holistic health expert Anthony Hartcher sits down with hypnotherapist Peter McLaughlin to explore how the subconscious mind shapes your health, emotions, and behaviours — and how hypnotherapy can help release deep‑rooted trauma.Peter shares his remarkable personal journey through chronic illness, emotional healing, and spiritual growth, including:✨ Discovering the mind–body connection during his leukemia diagnosis✨ How subconscious programming drives 94% of thoughts and actions✨ Why unresolved trauma keeps resurfacing in anxiety, stress, and physical symptoms✨ How Havening, hypnosis, and muscle testing help uncover and heal emotional blockages✨ The role of forgiveness, inner‑child work, and spiritual insight in true healingYou'll learn practical ways to understand your subconscious mind, identify emotional triggers, and begin releasing the past so you can feel lighter, calmer, and more empowered.Whether you're struggling with stress, trauma, anxiety, or repeating patterns, this episode will give you new clarity and hope.About Peter McLaughlinPeter McLaughlin is a certified Hypnotherapist and Life Coach who embarked on a transformative journey following a critical leukemia diagnosis in 2003. This life-altering moment led him to explore the powerful connection between the mind, spirit, and overall health. Peter's expertise in hypnotherapy is bolstered by his formal training at the American Academy of Hypnotherapy and his studies in Neuro-Linguistic Programming. He is also the creator of the popular YouTube channel, BlueSky Hypnosis, with over 127,000 subscribers, and an accomplished author working on his book, "Healing the Wounds of Time." His dedication to service is evident in his 15 years as a volunteer firefighter and EMT.

Building a successful sales career isn't just about hitting quotas—it's about intentional career planning, fostering creativity, and creating environments where talent can flourish. Too many organizations focus solely on product training while neglecting the human element that drives revenue growth. In this conversation with Edward Allen, Chief Revenue Officer at Measurabl, we explore how strategic career development and creative thinking can transform both individual trajectories and organizational performance. Edward shares insights from his 30-year journey through financial services and technology, revealing how simple yet structured approaches to talent development can reduce attrition and accelerate growth.          The Power of Structured Career Conversations Edward discusses his quarterly career development framework—a departure from traditional annual reviews that often come too late. These conversations focus on understanding what employees truly want to do, what they don't enjoy, and exploring possibilities they may not even know exist within the organization. Creating Roles That Don't Exist One of the most compelling aspects of our discussion centers on encouraging team members to pitch entirely new roles. Edward shares his own experience of giving up a $400 million book of business to create a new position that ultimately quadrupled revenue for underperforming divisions. Revenue Hackathons and Cross-Functional Innovation We explore how bringing together diverse perspectives—from finance to legal to frontline sales reps—can solve complex business challenges in unexpected ways. Edward explains how cognitive diversity becomes an accelerant for innovation when you create the right forum for ideas to emerge. Here's what you can expect to gain from this episode: ·        A framework for conducting meaningful quarterly career development conversations that reduce surprise departures ·        Strategies for identifying and developing hidden internal talent through cross-functional moves ·        Methods for ensuring junior team members' voices are heard and valued in revenue planning ·        The importance of portable skills training that benefits both current performance and future career growth ·        How to structure feedback systems that encourage innovation from the bottom up Edward's approach challenges conventional hierarchical thinking and demonstrates how investing in people development directly correlates to revenue outcomes. Whether you're managing a small team or leading a large organization, these principles can help you build a culture where creativity thrives and careers flourish. Key Moments of This Episode 00:00:52 - Introduction to Edward Allen and Measurabl Mario introduces Edward Allen, Chief Revenue Officer of Measurabl, a sustainability data and technology company. Edward shares his 30-year career journey from Goldman Sachs to leading revenue teams, highlighting his transition from financial services to fintech and his current role at Measurabl. 00:04:23 - From Acting Dreams to Sales Success Edward reveals his unexpected career path, sharing how he initially pursued acting at the American Academy of Dramatic Arts before pivoting to Goldman Sachs. This personal story demonstrates the importance of taking risks and finding your true calling in professional development. 00:06:48 - Building Structured Career Development Systems Edward discusses implementing quarterly career development conversations with direct reports, moving beyond traditional annual reviews. He emphasizes asking "how do you like your job?" and creating formal processes to understand employee aspirations and reduce regrettable attrition. 00:14:00 - Investing in Portable Skills Training The conversation shifts to training philosophy, with Edward advocating for soft skills development over product training. He shares examples of negotiation training, social psychology, and certification programs that employees can take anywhere, creating value for both current and future roles. 00:20:35 - Creating Accountability for Career Development Edward explains how to systematize career development through metrics and KPIs, including personal development goals, manager scorecards, and tracking regrettable attrition. He emphasizes making career growth visible and celebrated within the organization to drive engagement and retention. 00:32:22 - Unlocking Hidden Internal Talent Discussion focuses on cross-functional moves and international opportunities. Edward advocates for 60-day internal job postings before external searches, sharing examples of unexpected internal candidates who became successful in new roles across different geographies and functions. 00:35:58 - Running Revenue Hackathons for Innovation Edward explains the concept of revenue hackathons, bringing together diverse teams including finance, legal, and sales operations to solve business challenges. He shares a success story of creating email-based contracting for Fortune 100 clients through collaborative innovation. 00:39:25 - Amplifying Junior Voices in Sales Culture The discussion covers strategies for ensuring junior employees' ideas are heard, including reverse-order meetings (starting with junior staff), documenting all feedback, and providing follow-up on suggestions. Edward emphasizes the importance of recognition and creating safe spaces for innovation. 00:54:23 - Contact Information and Closing Edward provides his contact details, and the hosts wrap up with his favorite movie recommendation. The episode concludes with information about the Modern Selling podcast and promotional content for productivity tools. About Edward Allen Edward Allen is the Chief Revenue Officer and member of the Executive Committee at Measurabl. Measurabl is the world's most widely adopted sustainability data and analytics platform, empowering over 1,000 customers across 93 countries to achieve great levels of profitability.  The company serves the needs of investment managers, asset owners, real estate operators and banks and insurance companies. Prior to Measurabl, Edward worked for 20 years at MSCI where he led strategy and grew top line revenue across a multitude of data and analytic businesses.  He started his career in financial services at Goldman Sachs in the Institutional Advisory Services group. Edward received his Bachelor's Degree in Political Science from Boston University, his Master's in Business Administration from HEC School of Management in Paris, also spending time studying at London Business School. Follow Us On: ·        LinkedIn ·        Twitter ·        YouTube Channel ·        Instagram ·        Facebook Learn More About FlyMSG Features Like: ·        LinkedIn Auto Comment Generator ·        AI Social Media Post Generator ·        Auto Text Expander ·        AI Grammar Checker ·        AI Sales Roleplay and Coaching ·        Paragraph Rewrite with AI ·        Sales Prospecting Training for Individuals ·        FlyMSG Enterprise Sales Prospecting Training Program Install FlyMSG for Free: ·        As a Chrome Extension ·        As an Edge Extension  

The Intro to AOX Course is coming to Tempe, AZ! Join us for a hands-on deep dive into the clinical and business systems behind predictable full-arch success. Seats are limited - register now to secure your spot. https://products.sharedpractices.com/tfap-intro-to-aox-2026 In this episode of The Full Arch Podcast, Dr. Steven Vorholt shares exciting news about being selected for a main podium presentation at the American Academy of Implant Dentistry and reflects on the long path that led there. He discusses how teaching, mentorship, and strategic visibility have shaped his career trajectory. The conversation explores why reputation compounds over time, how hosting local study clubs can build referral networks, and why saying no to smaller opportunities creates space for higher-impact growth. This episode highlights how intentional positioning, not luck, drives long-term professional authority. Key Highlights: Teaching Builds Mastery - Verbalizing and mentoring sharpen clinical skill and credibility Reputation Compounds - Authority is built through consistent presence in the right rooms Intentional Calendar Design - Strategic opportunity selection creates higher-impact growth

This member-driven podcast is a benefit of membership of the Arizona Chapter of the American Academy of Pediatrics (AzAAP) and is intended for AzAAP pediatric healthcare members. No information or content in this podcast is intended to substitute or replace a consultation with a healthcare provider or specialist. All non-healthcare providers should reach out to their child's pediatrician for guidance. Music: Wallpaper by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/4604-wallpaperLicense: http://creativecommons.org/licenses/by/4.0/ 

A2 THE SHOW #602Our next guest on A2 THE SHOW is Dr. Joy Kong, a UCLA-trained, triple board-certified physician and founder of Chara Health USA and the American Academy of Integrative Cell Therapy, where she leads the forefront of regenerative and integrative medicine. In this episode, Dr. Kong shares her journey beyond traditional medical training into stem cell therapy, peptides, ketamine treatment, and energy-based healing, breaking down how stem cells communicate to repair the body, clarifying misconceptions around ketamine for depression and PTSD, and exploring the real potential of regenerative medicine for conditions ranging from chronic illness and autism to addiction and mental health—while emphasizing personalized care, nutrition, and the importance of curiosity in shaping the future of medicine.⭐WEBSITE: https://joykongmd.com/

These days I sometimes have to remind myself to keep breathing. I think this is true of human beings across all of our differences and divides. But in a room in New York City just before the turn of this year, I was regrounded by this fierce and joyous conversation with Joy Harjo and Tracy K. Smith.  I invite you to settle into your soft breathing body with these two wise women as companions and with a sense of poetry as a technology, as Tracy describes in her new book: a technology for rising to our truest, highest selves, even amidst grief and mystery and danger, and bearing witness to each other as we do so.  I think all of us in the room left a little more lighthearted and alive as this conversation unfolded. I hope that will be your experience too.  Tracy K. Smith and Joy Harjo are former U.S. poet laureates, beloved On Being guests, and friends. They are each wildly and deservedly awarded and not just as poets — Tracy also as a teacher and professor at Harvard, Joy as a saxophonist and painter. We were brought together at Symphony Space in Manhattan to celebrate their newest books: Fear Less by Tracy and Girl Warrior by Joy. Find an excellent transcript of this show, edited by humans, on our show page.  Sign yourself and others up for The Pause to be on our mailing list for all things On Being and to receive Krista's monthly Saturday newsletter, including a heads up on new episodes, special offerings, recommendations, and event invitations. Joy Harjo was the 23rd Poet Laureate of the United States. Among many honors, she has received the Poetry Society of America's Frost Medal and a National Humanities Medal. She is the inau­gur­al Artist-in-Res­i­dence for the Bob Dylan Cen­ter in Tul­sa, Okla­homa. She lives on the Musco­gee Nation Reser­va­tion in Oklahoma. Her new book of essays is Girl Warrior. Forthcoming in 2026 is her 12th book of poetry and a new album co-produced with esperanza spalding. Tracy K. Smith was the 22nd Poet Laureate of the United States. She teaches at Harvard University, where she is Boylston Professor of Rhetoric and Oratory, Professor of African and African American Studies, and Susan S. and Kenneth L. Wallach Professor at the Harvard Radcliffe Institute. Among her many honors, she has been awarded the Pulitzer Prize for Poetry  and is a Chancellor of the American Academy of Arts and Sciences. Her new memoir is Fear Less. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of The Behavioral View, Nissa Van Etten, Olivia Teal, Elizabeth Barajas, and Yagnesh Vadgama discuss the evolution of outcomes-based care within applied behavior analysis (ABA). Drawing from extensive experience in both clinical practice and payer systems, Vadgama outlines the differences between traditional fee-for-service models and outcomes-based care frameworks. The panel explores how standardized assessments, aggregate data analysis, and empirically supported dosing recommendations can create greater alignment between providers and payers while maintaining individualized clinical decision-making. The discussion addresses administrative burden, prior authorization processes, value-based payment arrangements, caregiver involvement, social determinants of health, and interdisciplinary collaboration. Emphasis is placed on transparency, data-driven decision making, and protecting the integrity of behavior analytic practice while demonstrating measurable outcomes at both the individual and population levels. This course provides practical insight into how outcomes-based care models may shape the future of ABA service delivery. To earn CEUs for listening, click here, log in or sign up, pay the CEU fee, + take the attendance verification quiz to generate your certificate! Don't forget to subscribe and follow and leave us a rating and review. Show Notes:   References  Frazier, T. W., Youngstrom, E. A., Speer, L., Embacher, R., Law, P., Constantino, J., Findling, R. L., Hardan, A. Y., & Eng, C. (2014). Validation of proposed DSM-5 criteria for autism spectrum disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 53(1), 28–40. https://doi.org/10.1016/j.jaac.2013.10.012  Frazier, T. W., Klingemier, E. W., Beukemann, M., Speer, L., Markowitz, L., Parikh, S., & Strauss, M. S. (2021). Development and validation of the Autism Impact Measure (AIM). Journal of Autism and Developmental Disorders, 51, 3407–3421. https://doi.org/10.1007/s10803-020-04795-1  Smith, P. C., Sagan, A., Siciliani, L., & Figueras, J. (2023). Building on value-based health care: Towards a health system perspective. Health Policy, 138, 104918. https://doi.org/10.1016/j.healthpol.2023.104918    AI.Measures Scientific Support   Ferguson, E. F., Frazier, T. W., Hardan, A. Y., & Uljarević, M. (2025). Challenging behavior domains in individuals with neurodevelopmental genetic syndromes: The role of psychological features. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 0(1), 1-12      Frazier, T. W., Huba, K., Frazier, A. R., Womack, R. A., Youngstrom, E. A., Chetcuti, L., Hardan, A. Y., & Uljarevic, M. (2025). Maximizing accurate detection of divergence from normative expectation in behavioral intervention outcome assessment. Research in Autism, 126, 202646.      Frazier, T. W., Youngstrom, E. A., Frazier, A. R., & Uljarevic, M. (2025). A critical appraisal of the measurement of adaptive social communication behaviors in the behavioral intervention context. Behavioral Sciences, 15(6), 722      Frazier, T.W., Helton, M., Akouri, C., Chetcuti, L., Uljarevic, M. (2025) Identifying Reliable Change In Outcome Assessments for Behavioral Intervention. Behavioral Interventions.      Frazier, T. W., Dimitropoulos, A., Abbeduto, L., Armstrong-Brine, M., Kralovic, S., Shih, A., Hardan, A. Y., Youngstrom, E. A., Uljarevic, M., Verbal Beginnings, T. (2024). Psychometric evaluation of the Autism Symptom Dimensions Questionnaire. Developmental Medicine and Child Neurology.      Frazier, T. W., Busch, R. M., Klaas, P., Lachlan, K., Jeste, S., Kolevzon, A., Loth, E., Harris, J., Speer, L., Pepper, T., Anthony, K., Graglia, J. M., Delagrammatikas, C., Bedrosian-Sermone, S., Beekhuyzen, J., Smith-Hicks, C., Sahin, M., Eng, C., Hardan, A. Y., & Uljarevic, M. (2023). Development of informant-report neurobehavioral survey scales for PTEN hamartoma tumor syndrome and related neurodevelopmental genetic syndromes. Am J Med Genet A, 191(7), 1741-1757. https://doi.org/10.1002/ajmg.a.63195      Frazier, T. W., Crowley, E., Shih, A., Vasudevan, V., Karpur, A., Uljarevic, M., & Cai, R. Y. (2022). Associations between executive functioning, challenging behavior, and quality of life in children and adolescents with and without neurodevelopmental conditions. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2022.1022700      Frazier, T. W., Dimitropoulos, A., Abbeduto, L., Armstrong-Brine, M., Kralovic, S., Shih, A., Hardan, A. Y., Youngstrom, E. A., Uljarevic, M., & Quadrant Biosciences - As You Are Team. (2023). The Autism Symptom Dimensions Questionnaire: Development and psychometric evaluation of a new, open-source measure of autism symptomatology. Developmental Medicine and Child Neurology. https://doi.org/10.1111/dmcn.15497      Frazier, T. W., Dimitropoulos, A., Abbeduto, L., Armstrong-Brine, M., Kralovic, S., Shih, A., Hardan, A. Y., Youngstrom, E. A., Uljarevic, M., Womack, R., Wolf, D., Chappell, N., & Verbal Beginnings Team. (2024). Psychometric Evaluation of the Autism Symptom Dimensions Questionnaire (ASDQ). Developmental Medicine and Child Neurology.      Frazier, T. W., Hyland, A. C., Markowitz, L. A., Speer, L. L., & Diekroger, E. A. (2020). Psychometric evaluation of the revised child and family quality of life questionnaire (CFQL-2). Research in Autism Spectrum Disorders, 70. https://doi.org/https://doi.org/10.1016/j.rasd.2019.101474      Frazier, T. W., Khaliq, I., Scullin, K., Uljarevic, M., Shih, A., & Karpur, A. (2022). Development and psychometric evaluation of the open-source challenging behavior scale. Journal of Autism and Developmental Disabilities. https://doi.org/https://doi.org/10.1007/s10803-022-05750-5      Frazier, T. W., Krishna, J., Klingemier, E., Beukemann, M., Nawabit, R., & Ibrahim, S. (2017). A Randomized, Crossover Trial of a Novel Sound-to-Sleep Mattress Technology in Children with Autism and Sleep Difficulties. J Clin Sleep Med, 13(1), 95-104. https://doi.org/10.5664/jcsm.6398      Frazier, T. W., Busch, R. M., Klass, P., Crowley, E., Lachlan, K., Jeste, S., Kolevzon, A., Loth, E., Harris, J., Pepper, T., Anthony, K., Graglia, J. M., Helde, K., Delagrammatikas, C., Bedrosian-Sermone, S., Smith-Hicks, C., Sahin, M., Eng, C., Hardan, A. Y., . . . Uljarevic, M. (2024). Quantifying Neurobehavioral Profiles across Neurodevelopmental Genetic Syndromes and Idiopathic Neurodevelopmental Disorders. Developmental Medicine and Child Neurology. https://doi.org/https://doi.org/10.1111/dmcn.16112      Uljarevic, M., Cai, R. Y., Hardan, A. Y., & Frazier, T. W. (2022). Development and validation of the Executive Functioning Scale. Front Psychiatry, 13, 1078211. https://doi.org/10.3389/fpsyt.2022.1078211      Uljarevic, M., Spackman, E. K., Cai, R. Y., Paszek, K. J., Hardan, A. Y., & Frazier, T. W. (2022). Daily living skills scale: Development and preliminary validation.   Frazier, T. W., Helton, M., Akouri, C., Chetcuti, L., & Uljarevic, M. (2025). Identifying reliable change in outcome assessments for behavioral interventions. Behavioral Interventions, 40, e70007. https://doi.org/https://doi.org/10.1002/bin.70007    Resources  CentralReach. (n.d.). AI Measures (AIM). https://centralreach.com 

Interview recorded - 19th of February, 2026On this episode of the WTFinance podcast I had the pleasure of welcoming on Barry Eichengreen. Barry is a renowned economist and Professor of Economics and Political Science at the University of California, Berkeley, where he has taught since 1987. He is also the author of many books, including the upcoming book “Money Beyond Borders: Global Currencies from Croesus to Crypto”During our conversation we spoke about his thoughts on the economy, the K-shaped economy, geopolitical shift, move away from the US dollar, what it means for the future and more. I hope you enjoy!0:00 - Introduction1:08 - Overview of the economy2:18 - K-shaped economy3:41 - Geopolitical shift6:13 - Europe becoming a world power?9:23 - US currency12:53 - China be trusted?14:58 - Precious metals movements17:09 - Next reserve currencies?19:58 - US Dollar devaluing21:47 - Bifurcating currency world23:56 - Influence for writing the book?25:58 - Any surprises?28:00 - One message to takeaway?Barry Eichengreen is George C. Pardee & Helen N. Pardee Chair and Distinguished Professor of Economics and Political Science at the University of California, Berkeley, where he has taught since 1987. He is a Research Associate of the National Bureau of Economic Research (Cambridge, Massachusetts) and Research Fellow of the Centre for Economic Policy Research (London, England). In 1997-98 he was Senior Policy Advisor at the International Monetary Fund. He is a fellow of the American Academy of Arts and Sciences (class of 1997). Professor Eichengreen is the convener of the Bellagio Group of academics and economic officials and chair of the Academic Advisory Committee of the Peterson Institute of International Economics. He has held Guggenheim and Fulbright Fellowships and has been a fellow of the Center for Advanced Study in the Behavioral Sciences (Palo Alto) and the Institute for Advanced Study (Berlin). He is a regular monthly columnist for Project Syndicate. His books include The Populist Temptation: Economic Grievance and Political Reaction in the Modern Era (2018), How Global Currencies Work: Past, Present, and Future, with Livia Chitu and Arnaud Mehl, (2017), The Korean Economy: From a Miraculous Past to a Sustainable Future (Harvard East Asian Monographs) with Wonhyuk Lim, Yung Chul Park and Dwight H. Perkins, (2015), Renminbi Internationalization: Achievements, Prospects, and Challenges, co-edited with Masahiro Kawai, (2015), Hall of Mirrors: The Great Depression, The Great Recession, and the Uses-and Misuses-of History, (2015). He was awarded the Economic History Association's Jonathan R.T. Hughes Prize for Excellence in Teaching in 2002 and the University of California at Berkeley Social Science Division's Distinguished Teaching Award in 2004. He is also the recipient of a doctor honoris causa from the American University in Paris.Barry Eichengreen - Website - https://eml.berkeley.edu/~eichengr/X - https://x.com/B_EichengreenBook - https://press.princeton.edu/books/hardcover/9780691280530/money-beyond-borders?_glWTFinance - Instagram - https://www.instagram.com/wtfinancee/Spotify - https://open.spotify.com/show/67rpmjG92PNBW0doLyPvfniTunes - https://podcasts.apple.com/us/podcast/wtfinance/id1554934665?uo=4Twitter - https://twitter.com/AnthonyFatseas

Ukraine will emerge from this war with enormous debt. The conventional wisdom treats that as an obstacle: investors weigh it before committing capital, and the burden slows the recovery before it starts. Yuriy Gorodnichenko and Maurice Obstfeld of UC Berkeley argue the opposite. A thorough restructuring of Ukraine's war debts – including, for sufficiently large obligations, outright forgiveness – is not just politically defensible but economically essential for attracting private investment. The bill for rebuilding and growing Ukraine, Gorodnichenko estimates, is $40 billion a year: $20 billion to replace destroyed capital, $10 billion to stop Ukraine falling behind its Eastern European peers, and $10 billion to start closing the gap. Put that figure next to what Poland absorbed in FDI during its post-communist transition, or the €200 billion of Russian state assets currently immobilised in Euroclear, or the budgetary support Ukraine has been receiving since 2022 – and it looks achievable. The harder challenge, they argue, is not raising $40 billion. It is directing it: towards investment rather than consumption. Ukraine didn't grow in the post-Soviet era at the rate that its neighbours achieved. EU accession momentum and secure borders can be a signal to investors that this time the trajectory will be different.The research behind this episode:Gorodnichenko, Yuriy, and Maurice Obstfeld. 2026. "You Only Live Twice: Financial Inflows and Growth in a Westward-Facing Ukraine." Economic Policy: Papers on European and Global Issues, special issue: "What's Next for Ukraine?"To cite this episode:Phillips, Tim. 2025. "You Only Live Twice: Financial Inflows and Growth in a Westward-Facing Ukraine." Economic Policy: Papers on European and Global Issues (podcast).Assign this as extra listening — the citation above is formatted and ready for a reading list or VLE.About the guestsYuriy Gorodnichenko is a CEPR Research Fellow and Professor of Economics at the University of California, Berkeley, where he leads CEPR's Ukraine Initiative. His research spans monetary policy, fiscal policy, and the macroeconomics of growth and business cycles.Maurice Obstfeld is a CEPR Distinguished Fellow and Class of 1958 Professor of Economics at the University of California, Berkeley. He served as Chief Economist of the International Monetary Fund from 2015 to 2018, and as a member of the Council of Economic Advisers under President Obama from 2014 to 2015. He is also a Fellow of the Econometric Society and the American Academy of Arts and Sciences.Research cited in this episodeThe discussion of debt overhang draws on a body of work from the 1980s developing-country debt crises, notably the insight that for sufficiently indebted countries, debt reduction can increase the expected value of what creditors recover. Gorodnichenko and Obstfeld apply this framework directly to Ukraine's war debts, arguing that deep restructuring – supported by bilateral official creditors, many of whom are European – is a prerequisite for private investment to follow.The €200 billion figure for immobilised Russian central bank assets held at Euroclear is the basis for Obstfeld's proposal of a reparations loan that would give Ukraine immediate access to large-scale resources, with repayment contingent on Russian reparations. This is discussed in more detail in the related reading below.More in the "What's Next for Ukraine?" seriesThis episode is the first in a three-part series based on papers presented at the inaugural Economic Policy winter conference, Paris, December 2025. Episodes 2 and 3, on rebuilding and the labour market, are forthcoming.Related reading on VoxEUYou only live twice: A growth strategy for Ukraine — Gorodnichenko and Obstfeld's own VoxEU column summarising the key arguments in this paper: why $40 billion a year is achievable, what the policy levers are, and why the window matters.Euroclear and the geopolitics of immobilised Russian assets — The legal and financial context behind the €200 billion of Russian central bank assets frozen at Euroclear, and what it would take to use them for a reparations loan to Ukraine.Using the returns of frozen Russian assets to finance the victory of Ukraine — A VoxEU proposal for channelling the interest income generated by frozen Russian assets to finance Ukraine's needs, without requiring the more politically contested step of confiscating the assets themselves.Ukraine's recovery challenge — An earlier VoxEU overview of the reconstruction task: the scale of damage, the role of EU accession, and the two-phase approach to restoring growth.

Neurologic complications of hematologic disorders are frequently encountered in clinical practice and can involve both the central and peripheral nervous systems. Early recognition and appropriate management in collaboration with a hematologist are essential to reduce morbidity and mortality. In this episode, Kait Nevel, MD, speaks with Lauren Patrick, MD, and Mark Terrelonge, MD, MPH, authors of the article "Neurologic Complications of Hematologic Disorders" in the Continuum® February 2026 Neurology of Systemic Disease issue. Dr. Nevel is a Continuum® Audio interviewer and a neurologist and neuro-oncologist at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Patrick is an assistant professor of neurology at the University of California, San Francisco, in San Francisco, California. Dr. Terrelonge is an associate professor of neurology at the University of California, San Francisco, in San Francisco, California. Additional Resources Read the article: Neurologic Complications of Hematologic Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @IUneurodocmom Full episode transcript available here Dr Nevel: Thick blood, thin blood. These are terms often used by patients and caregivers to describe some of the hematologic disorders that can lead to neurological diseases such as stroke. So, when should we consider a hematologic disorder as a potential cause for neurological conditions, such as stroke or neuropathy. Today I have the opportunity to interview Drs Lauren Patrick and Mark Terrelonge to learn more about neurologic complications of hematologic disorders in their recent article in Continuum. Dr Jones: This is Dr Lyell Jones, editor-in-chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Nevel: Hello, this is Dr Kate Nevel. Today I'm interviewing Drs Lauren Patrick and Mark Terrelonge about their article on neurologic complications of hematologic disorders. This article appears in the February 2026 Continuum issue on neurology of systemic disease. Welcome to the podcast, and please introduce yourself to the audience. Dr Patrick: Thank you for having us. We're both thrilled to be here. I'm Lauren Patrick, a vascular neurologist and assistant professor at the University of California, San Francisco, and program director for the Vascular Neurology Fellowship here. Dr Terrelonge: And I'm Mark Terrelonge, I'm an associate professor of neurology and neuromuscular medicine here at UCSF and one of the associate program directors for the adult neurology residency. Nice to meet you. Dr Nevel: Nice to meet you both. Really looking forward to getting into your article and learning more. So, to kind of kick us off, I always like to ask what do you think is the most important takeaway from your article for the practicing neurologist? And maybe since there are two of you and I suspect you covered slightly different aspects of this article, maybe you could give us two most important takeaways. Dr Patrick: Sure. I think the biggest takeaway is to keep hematologic disorders on the differential when evaluating patients with neurologic symptoms. Conditions like sickle cell disease, myeloproliferative neoplasms, or plasma cell dyscrasias and paraproteinemia can cause strokes or peripheral neuropathies, and many have specific and targetable treatments. The early recognition and collaboration with our hematology colleagues can truly change patient outcomes, whether that's by initiating cytoreductive therapy, managing thrombocytopenia, or optimizing antithrombotic therapy. Dr Nevel: Great. So, this is a really big and diverse topic. As always, I'm going to urge our listeners to read the article because there is a lot of really good stuff in your article that we just don't have time to get into during this interview today. But you cover a lot of different hematological disorders and how they can cause neurological complications. One of the major neurological complications of hematological disorders is cerebral vascular events. So, I'm hoping, Warren, that you can walk us through a little bit. When should we consider workup of potential hematologic disorder as a cause when we see a patient with ischemic stroke, because certainly not all patients with ischemic stroke should be getting a broad hematological disorder work up. So how can we kind of identify early on that there might be something else at play? Dr Patrick: Absolutely, great question. So, in many cases, the underlying hematologic disorder is already known, such as sickle cell disease or polycythemia vera. But sometimes stroke is the initial presentation or manifestation of the disease. So red flags can include young age, recurrent cryptogenic strokes or thrombosis, and unusual locations like the cerebral venous system. Laboratory clues such as unexplained erythrocytosis, thrombocytosis, thrombocytopenia, or hemolytic anemia should raise suspicion for an occult hematologic disorder. In the setting of acute illness, immune-mediated or heparin-induced thrombocytopenia or thrombotic microangiopathies should be suspected in patients that have hemorrhagic and or thrombotic complications, particularly when relevant lab disturbances are present. Acquired thrombophilia such as anti-phospholipid antibody syndrome should be considered in young patients with autoimmune disease, prior venous or arterial thrombotic complications, or pregnancy morbidity. Now, these are rare causes overall, but they're important to catch because the management can differ dramatically from our typical stroke care. Dr Nevel: Great. And what are some of the most common inherited or acquired thrombophilias and when should we be sending these labs? Dr Patrick: The hematologic causes really account for small minority of arterial strokes approximately one to two percent, but among those, sickle cell disease, anti-phospholipid antibody syndrome and the myeloproliferative neoplasms are the most common. Timing of testing is key. So, the genetic thrombophilia panels can be drawn at presentation, but lab values such as protein C, protein S, and antithrombin levels may be falsely low during acute thrombosis, so they're often repeated weeks later. Similarly, for anti-phospholipid antibody testing that should be done at presentation and when positive, confirmed at twelve weeks, since transient positivity can occur with affections or acute events. So, in patients that are already anticoagulated for anti-phospholipid antibody syndrome, testing becomes particularly tricky, especially with lupus anticoagulant assays. Some results need to be interpreted carefully or repeated when feasible. The main message is to collaborate early with our hematology colleagues to guide the timing and interpretation of these studies. Dr Nevel: Yeah, wonderful. Thank you. I'll ask some similar questions about neuropathy. So when should we consider an underlying hematologic disorder as being the cause for someone's neuropathy? Dr Terrelonge: So, luckily for a neurologist, then serum protein electrophoresis or an SPEP is already a part of the first pass evaluation for even the most common neuropathies we see, technically already considered every time we do an evaluation. However, we do know that most neuropathies progress very slowly and don't really lead to significant limitations in patient activities of daily living. And for those, the initial workup step, you may not need to do any additional search for any hematologic diseases after that first step. Within patients who start to have more unusual features with their neuropathy, including a rapid progression, early proximal weakness, significant and extremely painful neuropathies, significant ataxia, or new tremor or anything that's kind of outside of the garden variety neuropathy, then you should start to think about a hematologic cause. Additionally, if a patient already has a known hematologic malignancy or process before their neuropathy, there should be some form of assessment to see through exam or electrodiagnostically if the two are correlated. I do have to add one caveat, though, and that's just because someone has a hematologic malignancy or a paraprotein seen in their blood, their neuropathy and the neurologic syndrome don't necessarily have to be causally related. So, we have to do some additional testing to determine if the patient's presentation of the paraprotein are actually linked. Dr Nevel: Can you walk us through a little bit how we determine if they're associated or just coincidental? Dr Terrelonge: Yeah. So, for some of the proteins, there's a specific phenotype that will come with the specific protein. For example, an anti MAG proteinopathies or MAG standing for a myelin associated glycoprotein, it usually leads to a distal sensor and motor polyneuropathy where the most distal portions of nerves are affected. So, in that case, people might notice that they have numbness and weakness in their toes and their fingers, and it doesn't follow that typical length dependent pattern. So, in that case, if you have the anti mag neuropathy and the electrodiagnostic signature of an anti mag neuropathy along with the symptoms, you're more likely to think that the two are related then if not. Dr Nevel: Great. Thank you. And I was hoping you could speak a little bit more about amyloidosis just because I think that that's one that can be really tricky to diagnose. And I see patients, you know, have sometimes more drawn out evaluations or see multiple providers before a diagnosis is reached. So, can you speak a little bit more to how we diagnose amyloidosis in relationship to neuropathy or other neurological conditions and when we should push for more invasive testing like a nerve biopsy? Dr Terrelonge: So, amyloidosis certainly is a tricky diagnosis. I've been tricked by it and I think most of my neuromuscular colleagues have probably been tricked by it at least once. It's a hard diagnosis to make is it usually requires a pretty high index of suspicion, and also requires a tissue diagnosis to cinch. There're some patients who will come in with a prior history of amyloidosis and they're a little bit easier to figure out if the neuropathy is related. Maybe it's started in their heart or their kidney first and then you can just see if the type of amyloid they have usually deposits in nerve, and that may be enough. But if there's any diagnostic uncertainty, you could go forward with tissue biopsy. But it's patients in which the neuropathy is the first symptom that amyloidosis can be especially tricky to diagnose. It's a primarily light chain disease. So, if you do only an SPEP as a part of your initial neuropathy evaluation, you could miss it. But usually, the patients will have either a severely painful neuropathy, early autonomic dysfunction, or really prominent bilateral carpal tunnel syndrome. So, if they have any of those, usually we'll add in an amyloid workup as a part of that of the rest of the workup, which would include both light chain evaluations to see if there's any increase in Lambda or Kappa light chains and then also biopsy. Biopsy can be of the skin or fat pad first, which have reasonable sensitivity for picking up disease, but they're not necessarily a hundred percent. So if the suspicion remains high in those cases, a nerve biopsy should be considered. And the reason why this is important is that the chemotherapeutic agents that we have now can actually help arrest a lot of these diseases and stop further organ involvement. So, if you think about it, it is important to keep pushing and looking until you find it. Dr Nevel: Thank you so much for that. And a follow up question to that, once patients are started on appropriate therapy, the diagnosis is made, chemotherapy is started, what's the typical clinical course that you see in terms of their neuropathy? Do you ever see improvement or is it arrest of worsening? Dr Terrelonge: Usually for amyloid, there is an arrest of disease, but in some patients, they could have some improvement, not necessarily a dramatic improvement, but some patients could see some reversal of symptoms. That may not necessarily be because nerves injured nerves are regrowing, but because of reorganization of nerves to muscle, they could have some strength increases or at least less pain. Dr Nevel: Yeah, thank you. So, when should we involve a hematologist in aiding in the evaluation of patients we suspect may have an underlying hematological disorder? You guys really outlined very nicely in your article some of the laboratory workup or other workup like you just talked about with amyloidosis. But at what point in that workup should we reach out to our hematology colleagues? Dr Patrick: I would say almost always. So, these disorders are inherently multi-system and benefit from early co-management. In acute sickle cell stroke, for example, hematology helps direct emergent exchange transfusion. For myeloproliferative disorders they guide cyto reduction and long term antithrombotic strategy. And for antibody mediated or plasma cell disorders, hematology determines disease specific therapies. So, neurology may help with identifying the presentation, but the definitive management is almost always shared with our hematology colleagues. Dr Nevel: And as you both have mentioned that a lot of times in these cases, their hematologic disorder may be already known before they present with their neurological symptoms. So, I imagine obviously in those cases that a hematologist hopefully is already heavily involved in their care. What do you think is the most difficult aspect of identifying and diagnosing patients with neurologic illness as having an underlying hematological disorder? Dr Patrick: The hardest part is maintaining a high index of suspicion, especially since hematologic causes account for a very small minority of arterial strokes. Most strokes are from traditional vascular risk factors like you mentioned, or cardio embolism, so it's easy to stop diagnostic evaluation after standard studies have been performed. An example of a challenging case is a patient that's young, they've had recurrent cryptogenic stroke, and they could have antiphospholipid antibody syndrome, but it can be easy to miss if their antibody titers are borderline or if they're already anticoagulated, which would complicate retesting. So, it's about balancing the urge to over-test with recognizing the few cases where identifying A hematologic cause truly changes that management. Dr Terrelonge: And then on the neuropathy side, probably the hardest part is deciding what's causal and what's coincidence. Monoclonal gammopathy of unknown significance, or MGUS, is really common in older adults, so not every M-spike on an SPEP explains a neuropathy. And even sometimes there's times when the neurologic picture will develop a little bit faster than the hematologic one. So, it's hard to put the two together. Dr Nevel: Yeah. What's the most rewarding aspect of taking care of patients with complications from their hematologic disorders? Dr Patrick: It's deeply rewarding when a targeted diagnosis leads to a tangible improvement in that patient's care. For example, identifying A cryptogenic stroke is being due to myeloproliferative neoplasm or an inherited thrombophilia allows us to move from empiric treatment to possible disease specific strategy. It's really gratifying to give patients that clarity, to give them a diagnosis and in some cases prevent future events. Dr Terrelonge: Agreed. And even on the neuropathy side, almost all of the neuropathies that are hematologically related are treatable. So, it's so satisfying whenever you have a patient with say an anti-MAG neuropathy or Waldenström can start the patient on therapy, and you can see someone who's been having a progressive decline to stability and in those cases sometimes even significant recovery. Dr Nevel: Yeah, absolutely. Very rewarding when you can identify the problem and make it better. That's what it's all about. So, what are the future areas of research in this area? What do we still need to learn? Dr Patrick: There's still a lot to learn. I think we need better data on the safety of acute reperfusion therapy and antithrombotic agents, particularly in patients that are at dual risk for bleeding and thrombosis. Other examples, secondary prevention strategies and anti-phospholipid antibody syndrome. What's the best target INR? Do you add aspirin to warfarin or not? All of that is often left up to expert opinion. What's the best management for adults with sickle cell stroke? There are many open questions there. A lot of the protocols that we have in place for sickle cell patients that are adults as derived from pediatric literature and there's vast potential in terms of disease modifying therapies, especially in the fields of sickle cell disease and amyloidosis. And we'll need to reassess how those treatments may change neurologic outcomes. Dr Terrelonge: I think on the neuropathy side that having some form of new biomarkers to help us clearly know of the neuropathy and that hematologic illness are associated would be very helpful. On the treatment side, a lot of this is really being driven by the hematology space, but new therapies that treat hematologic plasma cell disorders, including some of the new BTK inhibitor, may be incorporated relatively soon into the algorithm for how we treat many of our patients. I'm excited to see what's to come from this. Dr Nevel: Wonderful. Thank you so much for sharing your knowledge with us today. I know I've certainly learned a lot by reading your article and through our discussion today. Highly encourage our listeners to read your wonderful article, which is a very thorough review of hematologic disorders and neurological complications. Again, today I've been interviewing Dr Lauren Patrick and Dr Mark Terrelonge on their article Neurologic Complications of Hematologic Disorders, which appears in the February 2026 Continuum issue on Neurology of Systemic Disease. Please be sure to check out Continuum Audio episodes from this and other issues. And as always, thank you so much to our listeners for joining today, and thank you so much to Lauren and Mark. Dr Terrelonge: Yeah, thank you so much for having us. Dr Patrick: Thank you so much for having us and for highlighting this topic. We hope the issue encourages clinicians to think broadly about hematologic causes of neurologic disease and to continue collaborating closely with our hematology colleagues. It's a complex but very fascinating intersection for both of our fields. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/AudioCME. Thank you for listening to Continuum Audio.

In this bonus episode, Nobel Prize-winning economist Daron Acemoglu joins Sam to challenge some of the most common assumptions about artificial intelligence's future. Drawing on his book Power and Progress, Daron argues that technology doesn't have a fixed destiny — and that today's choices will determine whether AI boosts workers or simply accelerates automation and inequality. He makes a case for focusing on new tasks that complement human skills, rather than replacing them, and warns that current incentives push AI toward centralization and automation by default. The conversation tackles productivity myths, reliability risks, and why regulation should proactively steer AI toward social good. Read the episode transcript here. Guest bio: Daron Acemoglu is an institute professor at MIT, faculty codirector of the James M. and Cathleen D. Stone Center on Inequality and Shaping the Future of Work, and a research affiliate at MIT's newly established Blueprint Labs. He is an elected fellow of the National Academy of Sciences, American Philosophical Society, the British Academy of Sciences, the Turkish Academy of Sciences, the American Academy of Arts and Sciences, the Econometric Society, the European Economic Association, and the Society of Labor Economists. He is also a member of the Group of Thirty. He has authored six books, including Power and Progress: Our Thousand-Year Struggle Over Technology and Prosperity with Simon Johnson. His work in economics has been recognized around the world, notably with the Nobel Prize in economic sciences, along with co-laureates Johnson and James A. Robinson, in 2024. *Please take our listener survey: ⁠⁠mitsmr.com/podcastsurvey⁠⁠ It's short — we promise! — and all respondents will receive a free MIT SMR article collection, "Maximizing the Value of Generative AI." Me, Myself, and AI is a podcast produced by MIT Sloan Management Review and hosted by Sam Ransbotham. It is engineered by David Lishansky and produced by Allison Ryder. We encourage you to rate and review our show. Your comments may be used in Me, Myself, and AI materials. ME, MYSELF, AND AI® is a federally registered trademark of Massachusetts Institute of Technology. All rights reserved.

In this Q&A episode of our neonatal opioid withdrawal syndrome (NOWS) series, we address challenging and nuanced clinical questions surrounding withdrawal, toxicology testing, and newborn exposures. Our host, Paul Wirkus, MD, FAAP, and guest Camille Fung, MD, review the early signs of withdrawal and discuss the process of obtaining consent for neonatal toxicology screening, clarifying when testing is considered diagnostic and how results may have reporting implications.We also explore common clinical scenarios, including the impact of maternal fentanyl administered via epidural on newborn toxicology results, and how in utero SSRI exposure may present with symptoms such as apnea, posturing, or seizure-like activity. The conversation further examines the effects of prenatal THC exposure, addressing common misconceptions, potential neonatal impacts, and the persistence of THC in breastmilk.Throughout the discussion, the emphasis remains on careful clinical assessment, clear communication with families, and a nonjudgmental, evidence-based approach to care.Have a question? Email questions@vcurb.com.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Brian Moreland recently made waves on Broadway as a producer of the groundbreaking revival of Othello, starring Denzel Washington and Jake Gyllenhaal, and directed by Tony Award winner Kenny Leon. The production shattered box office records, becoming the highest-grossing play revival in global history. His impressive repertoire includes the Broadway revival of The Wiz, starring Wayne Brady and Deborah Cox; August Wilson's The Piano Lesson, directed by LaTanya Richardson Jackson and starring Samuel L. Jackson, Danielle Brooks, and John David Washington — which became the highest-grossing revival of the season; The Lifespan of a Fact, featuring Cherry Jones, Daniel Radcliffe, and Bobby Cannavale; Sea Wall / A Life, a moving dual narrative with Jake Gyllenhaal and Tom Sturridge; and The Sound Inside, a compelling drama headlined by Mary-Louise Parker. Hailing from California, Brian now calls New York City home, where he continues to shape the cultural landscape through his visionary storytelling and unwavering passion for the performing arts. His dedication to accessibility and equity in theatre is reflected in his active role with the Theatre Development Fund (TDF), an organization committed to expanding access to live performance. A respected leader within the industry, Brian serves on the Board of Governors of The Broadway League, where he also co-chairs the Multicultural Task Force, advocating for greater diversity and inclusion across the theatre community. He also holds leadership roles as a Board Director for NYC Tourism and Conventions, a Trustee of Broadway Cares/Equity Fights AIDS, and a Trustee of The American Academy of Dramatic Arts, where he helps support and guide the next generation of performing artists. In recognition of his impactful contributions, Brian has been honored with the Board of Directors Distinguished Service Award by the Audelco Awards and acknowledged by the Theatre Communications Group (TCG) for his continued service to the field. Through his compelling productions and steadfast leadership, Moreland has established himself as a transformative force in contemporary theatre. His work not only entertains but also uplifts and challenges audiences, enriching the cultural narrative with stories that reflect the depth, diversity, and complexity of the human experience.Joe Turner's Come and Gone is lead produced by Brian Anthony Moreland with casting by ARC Casting. 101 Productions, Ltd. is serving as general managers.For additional information, please sign up at www.JoeTurnerBway.comConnect with Brian Anthony Moreland:Website: https://www.bmorenowproductions.com/ Instagram: https://www.instagram.com/therealbrianmoreland/?hl=en TurnKey Podcast Productions Important Links:Guest to Gold Video Series: www.TurnkeyPodcast.com/gold The Ultimate Podcast Launch Formula- www.TurnkeyPodcast.com/UPLFplusFREE workshop on how to "Be A Great Guest."Free E-Book 5 Ways to Make Money Podcasting at www.Turnkeypodcast.com/gift Ready to earn 6-figures with your podcast? See if you've got what it takes at TurnkeyPodcast.com/quizSales Training for Podcasters: https://podcasts.apple.com/us/podcast/sales-training-for-podcasters/id1540644376Nice Guys on Business: http://www.niceguysonbusiness.com/subscribe/The Turnkey Podcast: https://podcasts.apple.com/us/podcast/turnkey-podcast/id1485077152

This week's Recast is from April 2020. Why This Episode Matters Now:In 2022, the war in Ukraine revealed something our partners had been experiencing but we hadn't fully articulated: the traditional model of intact, homogeneous teams wasn't sufficient for the emerging operational environment. Individuals with diverse expertise, geography, language, and allegiances needed to rapidly converge into what we call Tactical Swarms—heterogeneous cross-functional units that form, solve emergent problems, and disperse.Our recent white paper, The Fourth Generation of Military Special Operations Selection & Assessment, explores this evolution in depth. But six years ago, Preston laid the foundational concepts in this conversation with Coleman.What the Research Shows:Many operators who excelled at teamwork—performing with known, homogeneous teams—struggled with teaming: the ability to rapidly build cohesion within heterogeneous groups. This episode examines why routine versus critical communication and field observations across special operations, emergency medicine, and other high-stakes environments. In this episode, Preston and Coleman describe how tactical swarms and X teams differ from traditional team structures, and they distinguish between routine and critical communication and when teams must shift between them. Recent Research:Cline, P.B. (2026). The Fourth Generation of Military Special Operations Selection Assessment: A Community of Praxis [White paper]. Mission Critical Team Institute. DOI 10.13140/RG.2.2.28255.73121. https://missioncti.com/wp-content/uploads/2026/02/The-Fourth-Generation-of-Military-Special-Operations-Selection-Assessment_Final_2-Feb-26.pdf Falk, D., Cline, P., Donegan, D., & Mehta, S. (2023). A Novel Framework for Routine Versus Critical Communication in Surgical Education—Don't Take It Personally. Journal of the American Academy of Orthopaedic Surgeons, 31(3), 115–121. https://doi.org/10.5435/JAAOS-D-22-00912 https://missioncti.com/wp-content/uploads/2023/08/FINAL-A-Novel-Framework-for-Routine-Versus-Critical.pdf If you find value in this discussion, the best way to support our work and stay up to date on future episodes is to subscribe and leave us a quick rating or review. It helps us reach more people who need to hear these conversations.This episode contains a term that may be offensive; it is used to describe gendered communication dynamics. We have included it to accurately represent the event, and it is intended for educational purposes only.

Manual therapy is one of those topics that seems to quickly descend to polarised debates in musculoskeletal rehabilitation. Today, we're talking about what manual therapy looks like and does in the 2020s. Dr Jodi Young explains the mechanisms of manual therapy, the typical effects and why you might think about adding manual therapy as another tool in your physical therapy toolkit. Dr Young is the Director of Research for the Doctor of Science in Physical Therapy program at Bellin College in Green Bay, Wisconsin, where she mentors doctoral clinicians and helps turn clinical and educational research questions into meaningful, publishable research. She is also a fellow of the American Academy of Orthopaedic Manual Physical Therapists. ------------------------------ RESOURCES Modern definition and description of manual therapy: https://pubmed.ncbi.nlm.nih.gov/38457654/ Modern way to teach and practice manual therapy: https://pubmed.ncbi.nlm.nih.gov/38773515/ Living review of manual therapy mechanisms: https://pubmed.ncbi.nlm.nih.gov/40100908/ Unravelling the mechanisms of manual therapy: https://www.jospt.org/doi/10.2519/jospt.2018.7476 Developing manual therapy frameworks: https://www.jospt.org/doi/10.2519/josptopen.2023.0002 Integrating person-centred concepts and modern manual therapy: https://www.jospt.org/doi/full/10.2519/josptopen.2023.0812 How do patients believe manual therapy works? https://www.jospt.org/doi/10.2519/josptopen.2025.0149 Does it matter how you apply spinal manipulation? JOSPT Insights ep 221: https://pod.link/1522929437/episode/NmM0MTg4OGMtODMwMi00ZTA3LTg1NzUtYjY2ZjBiMThiZGUy

Send a textAbout Azinda MorrowDr. Azinda Morrow is currently an Associate Optometrist at Silicon Valley Eyecare Optometry & Contact Lenses in Santa Clara, CA. She earned her Doctor of Optometry degree from SUNY College of Optometry in 2017 and completed her residency in Cornea and Contact Lenses at the Illinois College of Optometry in Chicago, IL in 2018. After completion of her residency, she was an Assistant Clinical Professor at the SUNY College of Optometry / University Eye Center and responsible for clinical supervision of students and residents in both the Cornea / Contact Lens and Myopia Management clinics. In addition, she taught in pre-clinical laboratories and was involved in clinical research. Now in private practice, Dr. Morrow continues to provide full-scope care to patients of all ages, as well as continuing her passion of caring for patients with specialty contact lens and myopia management needs. Dr. Morrow is also a fellow of the American Academy of Optometry, and a member of the American Optometric Association.---Thanks to TEEM for their support of this episode. If you're considering or have ever considered getting a virtual team member for your practice check out hiredteem.com, mention The Myopia Podcast when signing up for a $250 dollar discount off of your first month's teem member.https://hireteem.com/myopia-podcast/

In this episode, Dr. Sarah Jebreil (@sarahjebreildds), an Accredited Member of the American Academy of Cosmetic Dentistry, shares her inspiring journey from working in her father's practice to becoming a renowned cosmetic dentist with her own brand. She discusses the significance of accreditation and how it has helped her achieve clinical excellence and build a reputable practice.KEY TOPICSDr. Sarah Jebreil's journey from her father's practice to creating her own brandThe prestigious AACD accreditation and its impact on her careerStrategies for young dentists to establish their own practicesThe importance of continuous learning and innovation in cosmetic dentistryBalancing patient satisfaction with clinical precisionRESOURCES & LINKSAACDFacially Generated Treatment Planning by Frank SpearSarah Jebreil on InstagramAmerican Academy of Cosmetic DentistryCONNECT WITH DR. SARAH JEBREIL:InstagramMessage on social mediaCHAPTERS00:00 - Introduction to Dr. Sarah Jebreil01:14 - Growing up in her father's practice02:44 - Achieving AACD accreditation05:17 - Building her own practice and brand09:47 - Practice management and team building12:20 - Setting fees and overcoming imposter syndrome14:46 - Managing patient expectations and satisfaction20:37 - Future trends in cosmetic dentistry_______Don't miss out on these deals: Prioritize your wellness—shop my daily essentials here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://teethmatterpod.com/store⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠COCOFLOSS - Use code TM20 to get 20% off ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://cocofloss.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ FIGS - Use referral code to get 20% off ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://fbuy.io/figs/elliehalabian⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠If you want to join the conversation about the realities of dentistry, follow: Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@_teethmatter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Ellie Halabian⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠__________________________If you enjoy the podcast, subscribe and rate ⭐️. If you think a friend will enjoy it, please share it with them.

Join us in Vegas for Podjam 3! Subscribe and Watch Interviews LIVE : On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. This show is Ad free and fully supported by listeners like you! Please subscribe now for as little as 5$ and gain access to a community of over 750 awesome, curious, kind, funny, brilliant, generous soul Peter J. Hotez, MD, PhD, is the founding dean of The National School of Tropical Medicine at Baylor College of Medicine in Houston, Texas, as well as director of the Texas Children's Hospital Center for Vaccine Development. He is an elected member of the Institute of Medicine of National Academies as well as the American Academy of Arts and Sciences. A pediatrician and an expert in vaccinology and tropical disease, Hotez has authored hundreds of peer-reviewed articles and editorials as well dozens of textbook chapters. www.peterhotez.org On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete Listen rate and review on Apple Podcasts Listen rate and review on Spotify Pete On Instagram Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on Twitter Pete Personal FB page Stand Up with Pete FB page

This week I'm talking to Nancy Rynes about her Near Death Experience.Nancy Rynes was riding her bicycle when a large SUV approached. The vehicle's driver, absorbed in texting while driving, plowed right into Rynes.Suffering from severe spinal and head injuries, Rynes knew she was dying. At that moment, she underwent the first of two life-changing near-death experiences—her consciousness split between her frightened, injured self laying on the road, and an impartial, peaceful observer-consciousness who watched as first responders fought to keep her alive. Her second, more lengthy near-death experience came days later, during the surgery that attempted to repair her traumatized spine.Rynes, a scientist and confirmed skeptic, was shown the wonders of Heaven, experiencing joy, love, and beauty on such a grand scale that she wept at its magnitude. She then met and spoke with a Being who gave her insights into life, love, and the wonders of Spirit. After her tour of Heaven, she was returned to her body to begin the long, slow process of recovering from injuries her surgeon affirms should have killed her.In her book 'Awakenings from the Light', Rynes recounts the amazing sights of Heaven, and explains the remarkable insights into life she returned with to share with others. She was gifted with a second chance—a precious opportunity to bring a little bit of Heaven into her life on Earth. The wisdom she passes on could well change your life as well.BioMy friends call me "the atheist who went to Heaven."I would never have thought I would be writing a book about spirituality and near-death experiences since I spent my adult life as a scientist and skeptic. Born Roman Catholic, I became an atheist, and later an agnostic, beginning in my late teens when I went off to university to study geology and archaeology. While I started out my education as an artist (at Chicago's American Academy of Art), I went on to earn a degree in geology from Northern Illinois University, then attended the University of Colorado, Boulder, for Masters-level coursework. The sciences taught me to base my views on things I could measure, and since spiritual matters were not measurable, for me they did not exist.During most of my adult life, a part of me hoped there was something more than just physical reality, but I never saw evidence for it. The skepticism remained until January of 2014, when the Divine gave me a wake-up call: an opportunity to return to Spirit! Since my near-death experience, I have returned to a more spiritual and creative life based on the wisdom I learned in Heaven.In the past, I have been an archeological artist, geologist, data analyst, and science/technical writer. But then Heaven threw me a curveball, one I desperately needed. Now I am writing and teaching about my experience of the Divine, what happens when we die, and how we can bring a little bit of "Heaven" to our lives on Earth.https://www.amazon.com/Awakenings-Light-Lessons-Death-Experience-ebook/dp/B010MBT4QC https://www.pastliveshypnosis.co.uk/https://www.patreon.com/ourparanormalafterlifeMy book 'Verified Near Death Experiences' https://www.amazon.com/dp/B0DXKRGDFP Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode 516 / Hilary HarnischfegerHilary Harnischfeger (b. 1972, Melbourne, Australia) earned her MFA from Columbia University, New York (2003) and her BFA from the University of Houston, Houston, TX (2001). The artist has had work included in institutional exhibitions at the Fairfield University Art Museum, Fairfield, CT (2023); Nerman Museum of Contemporary Art, Overland Park, KS (2016); State University of New York at Purchase, Purchase, NY (2016); the FLAG Art Foundation, New York, NY (2014); MOCA Cleveland, Cleveland, OH (2013); American University Museum at the Katzen Arts Center, Washington, DC (2013); the American Academy of Arts and Letters, New York, NY (2013); Dallas Contemporary, Dallas, TX (2010); Ballroom Marfa, Marfa, TX (2005); Artists Space, New York, NY (2005); and the Contemporary Arts Museum Houston, Houston, TX (2002); among others. Harnischfeger has had recent solo exhibitions at Clear Sky Gallery, Brooklyn, NY (2021); Rachel Uffner Gallery, new York, NY (2021, 2015); Halsey McKay Gallery, East Hampton, NY (2014); and Front Gallery, Houston, TX (2012). In 2007, Harnischfeger was the recipient of the Maria Walsh Sharpe Foundation Space Program Award. Her work is in the permanent collection of the Cleveland Museum of Art, Cleveland, OH; the Nerman Museum, Overland Park, KS; the Everson Museum of Art, Syracuse, NY; and the Fairfield University Art Museum, Fairfield, CT. Harnischfeger lives and works in Brooklyn, NY. 

Up in the middle of the night at 2:37 a.m. like clockwork? Toss and turn, desperately trying to slip into slumber? Eyes pop open at 4 a.m. though you'd really love to sleep in till at least 6? Are you just tired all the time? Welcome to the sleep syndrome of menopause–a common cluster of midlife sleep problems this week's guest Dr. Andrea Matsumura treats every day. We break down what's behind women's sleep woes, including sleep apnea, lifestyle factors, and of course menopause. She also shares her DREAM Method as a practical framework for getting a solid night's rest.Dr. Andrea Matsumura, MD, MS, FACP, FAASM is a board-certified sleep medicine physician, menopause expert, speaker, and founder of the D.R.E.A.M. Sleep Method™. Known as Sleep Goddess MD, she specializes in helping women optimize sleep, circadian rhythm, and health during midlife. She is board-certified in Internal and Sleep Medicine, trained at the University of Texas Health Science Center at San Antonio and Oregon Health & Science University, and previously built a women-focused sleep consult service at The Oregon Clinic. Dr. Matsumura currently serves as Medical Director at Cascadia Health, is a Fellow of the American Academy of Sleep Medicine, co-founder of the M/Power Menopause Collective, and a leader in the Sleep Is Good Medicine™ campaign. Her work has been featured in The New York Times, SHAPE, SELF, and CNN Underscored. You can learn more about her and her work at andreamatsumuramd.comResourcesYou Deserve to Get Good Sleep with Andrea Matsumura, MD (Episode 91)

Nearly 1,000 people in South Carolina have been infected in a measles outbreak that started in a largely unvaccinated community in October. Dr. Martha Edwards, president of the South Carolina chapter of the American Academy of Pediatrics, explains how this outbreak has spread so quickly.And, social justice groups are remembering the Rev. Jesse Jackson. We look at how his civil rights leadership led to some of the activism we see today with Bryan Stevenson, founder of the Equal Justice Initiative in Montgomery, Alabama.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Touching your toes, pulling your heel to your butt, stretching your calves by pushing against a wall—what if these classic stretches aren't helping the way you think they are? Discover what's really happening when you feel "tight" and the game-changing approach that will help you avoid injury and stay active for years and decades. Physical therapist Joanna Fisher is here to help us find what might serve us better than flexibility!   LET'S TALK THE WALK! Join here for support, motivation and fun! Wellness While Walking Facebook page Walking to Wellness Together Facebook GROUP Wellness While Walking on Instagram Wellness While Walking on Threads Wellness While Walking on Twitter Wellness While Walking website for show notes and other information wellnesswhilewalking@gmail.com   RESOURCES AND SOURCES (some links may be affiliate links) Dr. Joanna Fisher, PT, DPT, OCS, FAAOMPT* Website  Instagram  *Joanna is a licensed Doctor of Physical Therapy, an Orthopedic Clinical Specialist, and a Fellow of the American Academy of Orthopedic Manual Physical Therapists with advanced training in pelvic floor rehabilitation. Want to Level Up Your Mobility? Add Weights, nyt.com - has some mobility exercises More mobility move depictions to come! Follow us both on social media and check back here soon!   HOW TO RATE AND REVIEW WELLNESS WHILE WALKING How to Leave a Review on Apple Podcasts on Your iOS Device 1.   Open Apple Podcast App (purple app icon that says Podcasts). 2.   Go to the icons at the bottom of the screen and choose "search" 3.   Search for "Wellness While Walking" 4.   Click on the SHOW, not the episode. 5.   Scroll all the way down to "Ratings and Reviews" section 6.   Click on "Write a Review" (if you don't see that option, click on "See All" first) 7.   Then you will be able to rate the show on a five-star scale (5 is highest rating) and write a review! 8.   Thank you! I so appreciate this!   How to Leave a Review on Apple Podcasts on a Computer  1.   Visit Wellness While Walking page on Apple Podcasts in your web browser (search for Apple Podcasts or click here)  https://www.apple.com/apple-podcasts/ 2.   Click on "Listen on Apple Podcasts" or "Open the App" 3.   This will open Apple Podcasts and put in search bar at top left "Wellness While Walking" 4.   This should bring you to the show, not a particular episode – click on the show's artwork 5.   Scroll down until you see "Rating and Reviews" 6.   Click on "See All" all the way to the right, near the Ratings and Review Section and its bar chart 7.   To leave a written review, please click on "Write a Review" 8.   You'll be able to leave a review, along with a title for it, plus you'll be able to rate the show on the 5-star scale (with 5 being the highest rating) 9.   Thank you so very much!! OTHER APPS WHERE RATINGS OR REVIEWS ARE POSSIBLE Spotify Goodpods Overcast (if you star certain episodes, or every one, that will help others find the show)  Castbox Podcast Addict Podchaser Podbean   HOW TO SHARE WELLNESS WHILE WALKING Tell a friend or family member about Wellness While Walking, maybe while you're walking together or lamenting not feeling 100% Follow up with a quick text with more info, as noted below! (My favorite is pod.link/walking because it works with all the apps!) Screenshot a favorite episode playing on your phone and share to social media or to a friend via text or email! Wellness While Walking on Apple – click the up arrow to share with a friend via text or email, or share to social media Wellness While Walking on Spotify -- click the up arrow to share with a friend via text or email, or share to social media Use this universal link for any podcast app: pod.link/walking – give it to friends or share on social media Tell your pal about the Wellness While Walking website Thanks for listening and now for sharing! : )       DISCLAIMER Neither I nor many of my podcast guests are doctors or healthcare professionals of any kind, and nothing on this podcast or associated content should be considered medical advice. The information provided by Wellness While Walking Podcast and associated material, by Whole Life Workshop and by Bermuda Road Wellness LLC is for informational and entertainment purposes only. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment, and before undertaking a new health care regimen, including walking.     Thanks for listening to Wellness While Walking, a walking podcast and a "best podcast for walking"!

In today's podcast, we visit with Dr. Michael Repka, current president of the American Academy of Ophthalmology. Tune in to hear about AAO leadership efforts including advocacy, from Medicare to medical code values.    Subscribe to the podcast:  https://MayoClinicOphthalmology.podbean.com   Follow and reach out to us on X and IG: @mayocliniceye 

Ever catch yourself thinking, “I'm doing all the right things… so why do I still feel tired, foggy, or just off?” You're working out, trying to eat better, squeezing in sleep where you can, and yet your energy and longevity still feel like a question mark. If that sounds familiar, this episode of The Happy Hustle Podcast is going to land right where you need it.In this episode, I sit down with Dr. Joy Kong, a UCLA-trained, triple board-certified anti-aging physician, stem cell specialist, educator, and CEO. Dr. Joy is the founder of Chara Health and Chara Biologics, and she's deeply committed to advancing regenerative medicine in a way that is ethical, effective, and accessible. She also founded the American Academy of Integrative Cell Therapy, where she trains physicians around the world in stem cell therapies and cutting-edge regenerative practices.This conversation dives headfirst into stem cells, longevity, and what it actually means to optimize your health for the long game. Dr. Joy breaks down complex science in a way that feels grounded and practical. We explore how diet, exercise, sleep, and regenerative therapies can work together not just to help you live longer, but to live better. This episode matters because longevity isn't about chasing perfection or biohacking extremes. It's about understanding your body, making informed choices, and stacking small, intentional habits that compound over time.Here are a few powerful takeaways you'll walk away with.First, stem cells are not science fiction anymore. Dr. Joy explains what stem cell therapy actually is, how it works, and why it's becoming one of the most promising tools in regenerative medicine today. She also clears up common misconceptions and emphasizes the importance of quality, sourcing, and proper medical oversight.Second, longevity starts with the basics before the breakthroughs. While regenerative therapies are exciting, Dr. Joy reinforces that diet, movement, and sleep are still foundational. Stem cells and advanced treatments work best when your lifestyle is already supporting your body's natural healing processes.Third, education is the real power play in health. One of the most inspiring parts of Dr. Joy's journey is her commitment to teaching both patients and physicians. When you understand your options, you're no longer guessing or blindly outsourcing your health. You're making confident, informed decisions.Fourth, anti-aging is really about regeneration, not vanity. This episode reframes anti-aging as restoring function, reducing inflammation, and improving quality of life. It's not about looking younger. It's about feeling strong, clear, and capable for decades to come.Finally, serving others is the ultimate form of optimization. Dr. Joy's mission goes beyond medicine. Her work is rooted in service, integrity, and raising the standard of care across the industry. That alignment between purpose and profession is what truly defines a happy hustler.If you're curious about stem cells, longevity, or how to future-proof your health in a grounded, responsible way, this episode is absolutely worth your time. Do yourself a favor and listen to the full conversation. And if it resonates, share it with someone ready to take ownership of their health and hustle with intention.What does Happy Hustlin mean to you?Dr. Joy says if it's not fun, why are we doing this? So what's the whole point? You're spending eight hours a day at this place. I want you to have fun. So that's the happy hustling, but how to keep that state.Connect with Dr. JoyInstagramFacebookTiktokLinkedinTwitterYoutubeFind Dr. Joy on her website: https://joykongmd.com/ Connect with Cary!InstagramFacebookLinkedinTwitterYoutube Get a copy of his new book, The Happy Hustle, 10 Alignments to Avoid Burnout & Achieve Blissful BalanceSign up for The Journey: 10 Days To Become a Happy Hustler Online CourseApply to the Montana Mastermind Epic Camping Adventure“It's time to Happy Hustle, a blissfully balanced life you love, full of passion, purpose, and positive impact!”Episode Sponsors:If you're feeling stressed, not sleeping great, or your energy's been kinda meh lately—let me put you on to something that's been a total game-changer for me: Magnesium Breakthrough by BiOptimizers. This ain't your average magnesium—it's got all 7 essential forms that your body needs to chill out, sleep deeper, and feel more balanced. I take it every night and legit notice the difference the next day. No more waking up groggy or tossing and turning all nightIf you're ready to sleep like a baby, calm your nervous system, and optimize your recovery, go grab yours now at bioptimizers.com/happy and use code HAPPY10 for 10% OFF.

We've all seen it: the patient whose chart is “flagged” with a penicillin allergy, but when you dig into the history, the story doesn’t quite add up. Maybe it was a stomach ache in the 90s, or maybe they're just carrying a “inherited” allergy from a parent. In this episode of EM Pulse, we sit down with ED Clinical Pharmacist Haley Burhans to discuss why these labels are more than just a nuisance—they're a clinical liability—and how a simple tool can empower you to fix them on the fly. The Hidden Danger of the “Safe” Choice Choosing a non-beta-lactam antibiotic because of a questionable allergy label feels like the path of least resistance, but the data tells a different story. We explore how “playing it safe” can actually lead to: Worse Outcomes: Why second line antibiotics often mean higher treatment failure rates. The “Superbug” Factor: The surprising link between penicillin allergy labels and the rise of MRSA and VRE in our communities. The C. diff Connection: Why alternative choices might be setting your patient up for a much more difficult recovery. The Solution: The PEN-FAST Score How do you move from “I think this might not be a true allergy” to “I am confident this antibiotic is safe”? Haley introduces the PEN-FAST score, a validated scoring tool designed to risk-stratify patients based on a few key historical questions. The Mnemonic: We break down the PEN-FAST acronym so you know exactly which three questions to ask to risk-stratify your patient in seconds. IgE vs. The Rest: Learn to distinguish between the “true” dangerous hypersensitivity and the delayed reactions that shouldn’t stop you from using the best drug for the job. The “Amoxicillin Rash”: We dive into this common pediatric “gotcha.”, why many kids end up with a lifelong allergy label after a routine ear infection, and why it often has nothing to do with the drug itself. The Bottom Line: Patients with low PEN-FAST scores are considered low risk, making an oral challenge under observation in the ED a reasonable option. Higher scores may require shared decision-making or referral. Why the ED is the Perfect Place for a “Challenge” Delabeling isn’t just for the allergist’s office. We argue that the Emergency Department is actually the ideal setting to challenge these allergies. The “Oral Challenge”: Learn the practical steps for performing a trial dose in the department. Safety First: Why your environment and expertise make you uniquely qualified to handle the “what-ifs” better than anyone else. Key Takeaways Question the Label: The vast majority of reported penicillin allergies are inaccurate due to patients outgrowing the allergy or misinterpreting common side effects as allergic reactions. History is Everything: Dig deeper than just “rash.” Ask about the timing relative to the dose, specific appearance (hives vs. flat rash), and what treatment was required (epinephrine vs. antihistamines). Use PEN-FAST: Utilize this tool to objectify the risk. Document Tolerance: Even if you don’t fully delete the allergy label, if you successfully treat the patient with another beta-lactam (like ceftriaxone), document that tolerance clearly to aid future clinicians. Cephalosporins are likely safe: Later-generation cephalosporins generally have very low cross-reactivity and are usually safe options even in truly allergic patients How do you handle documented penicillin allergies? Do you use the PEN-FAST tool? Share your experience with us on social media @empulsepodcast or at ucdavisem.com Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Professor of Emergency Medicine at UC Davis Guests: Haley Burhans, PharmD, Emergency Medicine Clinical Pharmacist at UC Davis Resources: PEN-FAST Score on MDCalc Penicillin Allergy Evaluation Should Be Performed Proactively in Patients with a Penicillin Allergy Label – A Position Statement of the American Academy of Allergy, Asthma & Immunology Staicu ML, Vyles D, Shenoy ES, Stone CA, Banks T, Alvarez KS, Blumenthal KG. Penicillin Allergy Delabeling: A Multidisciplinary Opportunity. J Allergy Clin Immunol Pract. 2020 Oct;8(9):2858-2868.e16. doi: 10.1016/j.jaip.2020.04.059. PMID: 33039010; PMCID: PMC8019188. Yang C, Graham JK, Vyles D, Leonard J, Agbim C, Mistry RD. Parental perspective on penicillin allergy delabeling in a pediatric emergency department. Ann Allergy Asthma Immunol. 2023 Jul;131(1):82-88. doi: 10.1016/j.anai.2023.03.023. Epub 2023 Mar 27. PMID: 36990206. *** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.  

Dr. Nancy O'Hara, pediatrician and leading expert in PANS and PANDAS, joins me to unpack why some children experience sudden, dramatic changes in behavior, anxiety, OCD, tics, sleep, or emotional regulation following illness. For many families, these symptoms appear almost overnight and are often misdiagnosed as "just anxiety," behavioral issues, or psychiatric disorders, leaving parents confused, dismissed, and unsure how to help their child.   Together we explore:   - What PANS and PANDAS are, and how infections like strep, viruses, or tick-borne illness can trigger sudden neuropsychiatric symptoms in children. - What to assess to help you determine if your child has a generalized anxiety disorder or if it may be PANS/PANDAS that is the root cause of their symptoms. - Why PANS/PANDAS is often missed or misunderstood in both medical and mental health settings. - The three-pronged approach to treatment: Addressing the trigger, the immune system, and the child's emotional and behavioral symptoms. - How therapy, both for parents and children, can support recovery, even when symptoms have a medical origin. - Understanding that there is real hope for healing and that it's never too late to identify and address PANS or PANDAS.   This episode is designed to help parents and clinicians feel more informed, less alone, and more confident in recognizing when a child's behavior may be signaling something deeper. PANS and PANDAS are real, treatable conditions that deserve compassionate, comprehensive care.     LEARN MORE ABOUT MY GUEST:

In this episode, we continue our series on neonatal opioid withdrawal syndrome (NOWS) with a discussion of substance exposure in the perinatal period and the practical considerations surrounding testing and discharge planning. Our host, Paul Wirkus, MD, FAAP and guest Camille Fung, MD review the fundamentals of prenatal substance exposure and the rationale for testing, including what different methods - such as urine, meconium, and umbilical cord testing - can and cannot tell us. The conversation explores the limitations of testing and how results should be interpreted in the clinical and social context of each family.We also discuss discharge planning, including referrals to primary care pediatricians and child welfare agencies when appropriate, and what clinicians and families can expect regarding developmental follow-up. Throughout the episode, Dr. Fung emphasizes the importance of a nonjudgmental, supportive approach that fosters trust and promotes the best outcomes for infants and their caregivers.Have a question? Email questions@vcurb.com. They will be answered in week four.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In this episode, we continue our series on neonatal opioid withdrawal syndrome (NOWS) with a discussion of substance exposure in the perinatal period and the practical considerations surrounding testing and discharge planning. Our host, Paul Wirkus, MD, FAAP and guest Camille Fung, MD review the fundamentals of prenatal substance exposure and the rationale for testing, including what different methods - such as urine, meconium, and umbilical cord testing - can and cannot tell us. The conversation explores the limitations of testing and how results should be interpreted in the clinical and social context of each family.We also discuss discharge planning, including referrals to primary care pediatricians and child welfare agencies when appropriate, and what clinicians and families can expect regarding developmental follow-up. Throughout the episode, Dr. Fung emphasizes the importance of a nonjudgmental, supportive approach that fosters trust and promotes the best outcomes for infants and their caregivers.Have a question? Email questions@vcurb.com. They will be answered in week four.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Society of Plastic Surgeons has released an updated statement recommending against gender surgeries for anyone under the age of 18. While the American Medical Association has issued a similar stance, other organizations—including the American Academy of Pediatrics—argue that healthcare decisions should remain between families and doctors, and that surgical options should stay on the table for minors. Earlier this week, plastic surgeon and star of Netflix's Skin Decision: Before and After, Dr. Sheila Nazarian, joined FOX News Rundown host Dave Anthony to explain why many in her field believe minors should not "go under the knife" for transition procedures. Dr. Nazarian raised alarms over the lack of long-term data regarding the effectiveness of these treatments, emphasizing her belief that evidence-based medicine must be the sole guide for treating gender dysphoria in children. She also discussed the professional risks of speaking out, noting that many in the medical community fear political backlash for questioning current standards of care. We often have to cut our interviews short during the week, but we thought you might like to hear this conversation in its entirety. Today on a Fox News Rundown Extra, we share our full interview with plastic surgeon Dr. Sheila Nazarian. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Screens are ubiquitous in today's world, and concerns about how they affect kids are mounting. Last month, Australia banned social media use for kids under 16, with some European countries poised to follow. But what's the science on how neverending YouTube videos or TikToks affect kids' brains and bodies? Joining Host Flora Lichtman to discuss are neuroscientist John Foxe and behavioral developmental pediatrician Jenny Radesky.Guests:Dr. John Foxe is Director of The Del Monte Institute for Neuroscience at the University of Rochester in New York.Dr. Jenny Radesky is a developmental behavioral pediatrician at the University of Michigan in Ann Arbor. She's also co-Medical Director of the American Academy of Pediatrics Center of Excellence on Social Media and Youth Mental Health.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.